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In the field of ear surgery, research continues on new applications for surgical reconstruction. 
Polylactic- and polyglycolic acid (PLA and PGA)-based degradable biomaterials are in wide 
clinical use especially in orthopedic and craniomaxillofacial (CMF) surgery, and in general 
they have proved to be safe and well-tolerated implant materials. Thus far, they have not been 
used in reconstructive human middle ear surgery. Common problems related to implant 
surgery are microbial biofilm formation on medical implants in vivo and subsequent 
infection. A postoperative implant infection often leads to re-operation and implant removal. 
The present thesis clarifies the surface properties of polylactic-glycolic acid (PLGA) in 
relation to bacterial adherence—the first step in biofilm formation—and the biocompatibility 
of the material in the middle ear. Furthermore, a new application has been studied for imaging 
of the middle ear with a lower radiation dose than with the present computed tomography 
(CT) of the ear. This method, cone-beam computed tomography (CBCT), has been used 
particularly in dental and maxillofacial imaging, where it allows accurate, three-dimensional 
(3D) imaging of a defined area.
The first two studies of this thesis tested bacterial adherence onto the surfaces of PLGA and 
of two common implant materials used in ear surgery: silicone and titanium. In the first study 
(I), a method was developed for quantifying in vitro adherence of two common pathogens of a 
chronically or postoperatively infected ear, Staphylococcus aureus and Pseudomonas
aeruginosa, to the material surfaces, and for measuring the effect on adherence of a surface 
albumin coating. This method was utilized in the second work (II), where the adherence of 
these bacteria to PLGA, silicone, and titanium was studied and compared. In addition, the 
effect of albumin coating on adherence to these materials was tested and compared. Next, 
applicability of the PLGA material to reconstructive middle ear surgery was explored by 
study of its biocompatibility in the middle ear in an animal model (III) in which chinchillas 
were operated on, followed-up, and killed at 6 months postoperatively. In the experimental 
surgery, two kinds of PLGA implants were inserted into each animals’ middle ear. 
Biocompatibilities of the implanted materials were evaluated according to clinical and 
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histological findings. Suitability of the CBCT for imaging of the ear was tested by imaging 
human cadaver temporal bones and comparing scaled accuracies of the images created by 
CBCT with those constructed with traditional multislice helical CT (IV). In addition, to 
evaluate the clinical applicability of CBCT to otologic diagnostics, a study was conducted of 
CBCT imaging of middle ear implants and operated temporal bones (V). 
There proved to be no more bacterial adherence in vitro to the PLGA materials tested than to 
silicone and titanium. Of the materials studied, uncoated titanium clearly gathered the most 
bacteria, whereas differences in adherence levels between albumin-coated materials were 
smaller. Albumin coating significantly reduced bacterial adherence to every material tested. 
The biocompatibility of PLGA in the middle ear of the chinchilla was very good. In 
histological samples, only a mild inflammatory reaction was evident around the degrading 
PLGA plates. Clinically, no infections or extrusion of the implanted material occurred in the 
animals’ external auditory canal (EAC) or middle ear. Limited cone-beam CT was found to 
be at least as accurate as conventional multislice helical CT in showing the clinically and 
surgically important landmarks of the middle and inner ear. The effective radiation dose was 
essentially lower with the CBCT than with the helical CT used in this study. Visualization of 
the middle ear structures and implants of operated temporal bones was clear and of diagnostic 
value.
Based on the results of Studies I to III, it can be concluded that PLGA is a safe and well-
tolerated implant material in the middle ear area, and there is no greater in vitro adherence of 
S. aureus and P. aeruginosa to PLGA surfaces than to titanium and silicone. In addition, 
coating of these materials with albumin means that adherence of the bacteria to their surfaces 
can be substantially reduced, suggesting that this method may be useful in implant surgery as 
a preventive maneuver against postoperative infections. Based on the findings of Studies IV 
and V, cone-beam CT seems to be a promising new method for imaging the structures of the 
temporal bone. The diagnostic accuracy of CBCT corresponds to that of helical CT, while the 
radiation dose to patient per investigation remains lower with CBCT. Focused imaging with 
the lesser radiation exposure expands the possibilities for imaging the ear, especially when 
follow-up and limited uni- or bilateral examination is needed. 
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TIIVISTELMÄ (FINNISH SUMMARY) 
Välikorvaleikkauksiin usein liittyvä välikorvan ja kuuloluuketjun kirurginen rekonstruktio on 
tapauskohtainen ja haasteellinen. Rekonstruktion tavoitteena on luoda olosuhteet, jotka 
mahdollistavat hyvän kuulon sekä välikorvan säilymisen tulehduksettomana ja ilmapitoisena. 
Kroonisesti tulehtunut välikorva aiheuttaa johtumistyyppisen kuulonaleneman ja lisää mm. 
kolesteatooman eli ”helmiäiskasvaimen” kehittymisen riskiä. Välikorvan kirurgisessa 
rekonstruktiossa on käytetty implanttimateriaaleina perinteisesti potilaan omia kudoksia, 
luuta, rustoa ja lihaskalvoa, sekä tarvittaessa erilaisia hajoamattomia biomateriaaleja. Uusia 
tekniikoita ja rekonstruktiivisia biomateriaaleja kokeillaan ja kehitetään jatkuvasti. 
Ongelmana biomateriaalien käytössä voi olla bakteerien adherenssi eli tarttuminen vieraan 
materiaalin pintaan, mikä saattaa johtaa biofilmin muodostumiseen. Tämä voi aiheuttaa 
kroonisen, huonosti antibiootteihin reagoivan infektion kudoksessa, mikä usein käytännössä 
johtaa uusintaleikkaukseen ja implantin poistoon.
Maitohappo- ja glykolihappopohjaiset biologisesti hajoavat polymeerit ovat olleet kliinisessä 
käytössä istutteina jo vuosikymmeniä. Niitä on käytetty erityisesti osteosynteesimateriaaleina 
ortopediassa sekä kasvo- ja leukakirurgiassa ja hyödynnetty myös urologiassa ja 
verisuonikirurgiassa stenttimateriaaleina. Niitä ei ole toistaiseksi käytetty 
välikorvakirurgiassa. Tässä väitöskirjassa on selvitetty polylaktaatti-glykolaattien (PLGA) 
bakteeriadherenssia in vitro suhteessa kahden yleisen korvakirurgisen implanttimateriaalin, 
titaanin ja silikonin bakteeriadherenssiin. Lisäksi on tutkittu eläinkoemallissa PLGA:n 
biokompatibiliteettia välikorvassa.
Korvan kuvantamiseen käytetään ensisijaisesti tietokonetomografiaa (TT), koska sen avulla 
saadaan tarkkaa tietoa korvan luisista ja ilmapitoisista rakenteista. TT-tutkimuksen ongelmana 
on potilaan altistuminen suhteellisen korkealle sädeannokselle, joka kasvaa kumulatiivisesti, 
jos kuvaus joudutaan toistamaan. Väitöskirjatyö selvittää uuden, aiemmin kliinisessä työssä 
rutiinisti lähinnä hampaiston ja kasvojen alueen kuvantamiseen käytetyn rajoitetun 
kartiokeila-TT:n soveltuvuutta korvan alueen kuvantamiseen. Kyseinen tekniikka 
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mahdollistaa tarkan kolmiulotteisen kuvantamisen rajatulta alueelta suhteellisen pienellä 
sädeannoksella.
Väitöskirjan kahdessa ensimmäisessä osatyössä tutkittiin ja verrattiin kahden kroonisia ja 
postoperatiivisia korvainfektioita aiheuttavan bakteerin, Staphylococcus aureuksen ja 
Pseudomonas aeruginosan, adherenssia titaanin, silikonin ja kahden eri PLGA-materiaalin 
pintaan in vitro. Lisäksi tutkittiin materiaalien albumiinipinnoituksen vaikutusta 
bakteeriadherenssiin. Ensimmäisessä, tutkimusmetodeihin keskittyvässä osatyössä tutkittiin 
bakteeriadherenssia titaanilevyillä. Menetelmää hyödynnettiin edelleen toisessa osatyössä, 
jossa tutkittiin ja vertailtiin bakteerien adherenssia myös muihin biomateriaaleihin. 
Kolmannessa osatyössä tutkittiin eläinmallissa PLGA:n biokompatibiliteettia kokeellisessa 
välikorvakirurgiassa. Chinchillojen välikorviin istutettiin PLGA-materiaalia, eläimiä 
seurattiin, ja ne lopetettiin 6 kk:n kuluttua operaatiosta. Biokompatibiliteetin arviointi perustui 
kliinisiin havaintoihin sekä kudosnäytteisiin. Neljännessä osatyössä tutkittiin kartiokeila-TT:n 
soveltuvuutta korvan alueen kuvantamiseen vertaamalla sen tarkkuutta perinteisen spiraali-
TT:n tarkkuuteen. Molemmilla laitteilla kuvattiin kadavereista preparoituja ohimo- eli 
temporaaliluita korvan alueen kliinisesti ja kirurgisesti tärkeiden rakenteiden kuvantumisen 
tarkkuuden arvioimiseksi. Viidennessä osatyössä arvioitiin myös operoitujen temporaaliluiden 
ja välikorvaimplanttien kuvantumista kartiokeila-TT:ssa. 
Bakteeriadherenssitutkimuksissa osoittautui, että PLGA-materiaalin pintaan tarttui 
keskimäärin korkeintaan saman verran tai vähemmän bakteereita kuin silikonin. 
Pinnoittamaton titaanilevy keräsi bakteereita eniten. Albumiinipinnoitus vähensi 
bakteeriadherenssia merkitsevästi kaikilla materiaaleilla. Eläinkokeiden perusteella PLGA 
todettiin hyvin siedetyksi välikorvassa. Korvakäytävissä tai välikorvissa ei todettu infektioita, 
tärykalvon perforaatioita tai materiaalin esiin työntymistä. Kudosnäytteissä näkyi vain lievää 
tulehdusreaktiota ja fibriinin muodostumista implantin ympärillä. Temporaaliluutöissä 
rajoitettu kartiokeila-TT todettiin vähintään yhtä tarkaksi menetelmäksi kuin spiraali-TT 
välikorvan ja sisäkorvan rakenteiden kuvantamisessa, ja sen aiheuttama kertasäderasitus 
todettiin spiraali-TT:n vastaavaa selvästi vähäisemmäksi. Kartiokeila-TT soveltui hyvin 
välikorvaimplanttien ja postoperatiivisen korvan kuvantamiseen.
Osatöiden I-III perusteella voidaan todeta, että PLGA on välikorvakirurgiaan soveltuva, 
turvallinen ja kudosyhteensopiva biomateriaali. PLGA ei adheroi bakteereja in vitro enempää 
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kuin välikorvakirurgiassa implanttimateriaaleina jo pitkään käytetyt titaani tai silikoni. 
Kaikkien osatöissä testattujen biomateriaalien pinnoittaminen albumiinilla vähentää 
bakteerien adherenssia niihin merkittävästi, mikä puoltaa pinnoituksen käyttöä 
implanttikirurgiassa. Osatyöt IV ja V osoittavat, että kartiokeila-TT soveltuu korvan alueen 
kuvantamiseen. Sen tarkkuus kliinisesti tärkeiden rakenteiden osoittamisessa on vähintään 
samaa luokkaa kuin spiraali-TT:n. Yhden rajoitetun kartiokeila-TT-tutkimuksen potilaalle 
aiheuttama sädeannos on pienempi kuin nykyisen rutiinikäytössä olevan korva-spiraali-TT:n. 
Tämä tekee menetelmästä potilasturvallisemman vaihtoehdon spiraali-TT:lle erityisesti, jos 
potilaan tilanne vaatii seurantaa ja useampia kuvauksia, ja jos halutaan kuvata rajoitettuja 




Reconstruction in middle ear surgery is challenging in many ways. The ear surgeon has to 
create favorable circumstances for the healing process to ensure an aerated tympanum and the 
satisfactory hearing of the patient in the long term. To reach these goals, use of implant 
materials is often mandatory. Traditionally, the patient’s own bone, cartilage, and fascia have 
been used as grafting material. In addition, various kinds of biomaterials have shown variable 
success. Especially in radical operations, where lack of sufficient reconstruction material and 
structural support may constitute a problem, but also in other ear surgery as well, new, better 
operative techniques are desirable. 
Polylactic-acid (PLA)- and polyglycolic acid (PGA)-based biodegradable copolymers have 
long been used in orthopedic and craniomaxillofacial (CMF) surgery as osteosynthesis 
materials (Törmälä et al. 1998, Suuronen et al. 2000, Waris et al. 2004). They have also 
served as urethral stent material (Tammela and Talja 2003), and during the past 10 years, 
further applications have been under intensive research with promising results (e.g. tracheal 
and drug-releasing vascular stents made of polylactide frame) (Korpela et al. 1999, Hietala et 
al. 2001, Nalwa et al. 2001, Vogt et al. 2004). In clinical use, these polymers have proven safe 
implant materials with low complication rates. Thus far, they have not been routinely used in 
human middle-ear surgery, and only some experimental data exist about their applicability to 
myringoplasty (Feenstra et al. 1984), to drug-delivery in the middle ear (Goycoolea et al. 
1991, 1992, 1994), or to tympanostomy tubes (Massey et al. 2004). 
Every medical implant has the potential to become covered with microbial biofilm, a major 
cause of resistant postoperative infections (An and Friedman 1998, Lynch and Robertson 
2008). It is therefore desirable to find implant materials with surface characteristics 
unfavorable for bacterial adhesion and biofilm formation. Furthermore, different kinds of 
methods that could inhibit bacterial adherence onto the implant surface are under continuous 
development and research. In developing such a process, one of the goals is to make it easily 
applicable to clinical use. Coating of any material with human serum albumin (HSA)—a 
17
method known for four decades (Packham et al. 1969)—is a relatively simple way to convert 
the material surface so it becomes less susceptible to bacterial adhesion. Albumin coating has 
been applied in research into implant surgery in the past two decades (Zdanowski et al. 1993, 
An et al. 1996 and 1997), and it has also been used to prevent platelet adhesion in 
extracorporeal hemoperfusion systems and vascular surgery (Remuzzi and Boccardo 1993, al-
Khaffaf and Charlesworth 1996).
Radiological imaging of the ear is often required in planning surgical therapy of the middle 
ear or when follow-up of the disease—with or without operative treatment—is necessary. 
Computed tomography (CT) is basically the method of choice when imaging the ear because 
of the need for accurate visualization of the thin bony structures and air-filled spaces. Other 
imaging techniques with more specific indications, mainly magnetic resonance imaging 
(MRI), are complementary and sometimes also needed (Kösling and Bootz 2001, Maroldi et 
al. 2001, Williams and Ayache 2004). The significant disadvantage of the conventional 
multislice helical CT, however, is the relatively high radiation dose per investigation to which 
the patient is exposed. Furthermore, the dose increases cumulatively when repeated 
investigations are needed, as sometimes may be the case during follow-up. Clinical cone-
beam computed tomography (CBCT) is a relatively new imaging method developed for 
diagnostic three-dimensional (3D) imaging of dental and facial areas (Arai et al. 1999, 
Sukovic 2003). This technique is under ongoing development, and it has already been used 
for research and clinical purposes to image other objects as well (Robinson et al. 2005). One 
of the advantages of the CBCT, when compared with conventional helical CT, is its lower 
radiation dose per investigation when focusing the imaging on a limited field, e.g., 
unilaterally or on the diseased area only. This aspect does raise the question whether CBCT 
could be an alternative to helical CT in imaging the ear, in particular when repeated 
information from a relatively limited area is required. 
The purpose of this study was to investigate the bacterial adherence to polylactic-glycolic acid 
(PLGA) in comparison to common otologic implant materials, to test the effect of albumin 
coating on such adherence, to clarify the biocompatibility of PLGA in the middle ear, and to 




REVIEW OF THE LITERATURE 
2.1  CHRONIC OTITIS MEDIA AND CHOLESTEATOMA 
2.1.1  Definitions 
Chronic suppurative otitis media (CSOM) involves chronic inflammation of the middle ear 
and the mastoid mucosa. In addition, a nonintact tympanic membrane (TM) (perforation or 
tympanostomy tube) and otorrhea are present (Bluestone and Klein 1995). Adhesive otitis 
media involves permanent atelectasis and retraction of the TM such that the middle ear space 
is totally obliterated. No mucosal surfaces are present, since the TM is adherent to the 
auditory ossicles and promontory (Cummings et al. 1998). Chronic otitis media (COM) 
includes both adhesive and suppurative otitis media. 
Cholesteatoma is a non-neoplastic lesion consisting of keratinizing stratified squamous 
epithelium and desquamating epithelium of keratin within the middle ear or other 
pneumatized portions of the temporal bone. Cholesteatoma can be congenital or acquired; in 
the latter case it is associated with COM and related conditions (Bluestone and Klein 1995, 
Persaud et al. 2007). 
2.1.2  Epidemiology 
Chronic suppurative otitis media most often occurs in the first 5 years of life. Furthermore, it 
is most common in developing countries, in special populations (e.g., in children with 
craniofacial anomalies), and in certain racial groups. Prevalences of CSOM in children range 
from less than 1% up to 46% worldwide, being lowest in highly developed countries 
(Verhoeff et al. 2006). Adhesive otitis media may develop as a result of long-lasting chronic 
middle ear infection in a small percentage of the patients (Bluestone and Klein 1995, 
Cummings et al. 1998).
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The prevalence of cholesteatomas is unknown, and the incidence of all cholesteatomas has 
been estimated at 3 to 6 per 100 000 (Kazahaya and Potsic 2004). In a histopathological study 
of 144 temporal bones showing chronic otitis media (da Costa et al. 1992), cholesteatoma was 
found in 36% of the temporal bones with a perforated TM, and in 4% of the bones without. 
Congenital cholesteatoma is a rarity, accounting for 4 to 24% of cholesteatomas in children 
and 2 to 5% of all cholesteatomas (Kazahaya and Potsic 2004, Lazard et al. 2007). 
2.1.3  Etiology and pathogenesis
Several identified risk factors exist for development of CSOM, including a history of acute 
and recurrent otitis media, parental history of otitis media, and large day-care groups. The 
pathogenesis of CSOM is multifactorial, and both environmental and genetic factors 
contribute to the likelihood of the disease. In addition, pathology in the anatomy and 
physiology of the Eustachian tube (ET) is involved (Bluestone and Klein 1995, Seibert and 
Danner 2006, Verhoeff et al. 2006). Bacteria isolated in CSOM are most typically 
Pseudomonas aeruginosa, Staphylococcus aureus, Proteus spp. among the aerobes, and 
Bacteroides spp. among the anaerobes (Kenna et al. 1986, Fliss et al. 1990, 1992, Arguedas et 
al. 1994, Indudharan et al. 1999, Aslam et al. 2004). They can enter the middle ear either 
through the ET or from the external auditory canal (EAC) through a nonintact TM. Fungi may 
also be present. It is still unclear whether the bacteria play a role in the CSOM development 
or represent secondary contamination in the inflamed middle ear (Brook 1995). With growing 
evidence for bacterial biofilms’ being a major cause of resistant, chronic infections on tissue 
or implant surfaces (Costerton et al. 1999, Stewart and Costerton 2001), the existence of these 
biofilms in CSOM and infected cholesteatomas has become obvious (Post 2001, Chole and 
Faddis 2002, Hall-Stoodley et al. 2006). The eventual role of the biofilms in these diseases is 
under investigation and is yet to be clarified. 
Several hypothetical mechanisms for the pathogenesis of acquired cholesteatoma exist. 
Dysfunction of the ET has been assumed to be an important factor for development of a 
retraction pocket of the TM (Chao et al. 1996, Seibert and Danner 2006). ET dysfunction 
leads to negative pressure in the middle ear cavity, which first causes retraction and 
invagination of the TM, usually in its most elastic pars flaccida area, but may involve the 
whole TM as well (Palva 1990, Ramakrishnan 2007). Gradually, the pocket becomes filled 
with keratin and debris to form a continually expanding cholesteatoma (Semaan and Megerian 
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2006). Migration of the skin epithelial cells of the EAC over the TM perforation edges to the 
middle ear is another proposed mechanism, as well as basal cell invasion in the middle ear 
behind an intact TM (Palva 1990). There also exists some evidence for potential 
keratinization of the middle ear mucosa through metaplasia in vitamin A-deficient animals 
(Chole 1979), but this mechanism still remains highly controversial in the literature (Persaud 
et al. 2007). Recent findings suggest that apoptosis plays an important role in the pathogenesis 
of cholesteatoma; it also seems to participate in the differentiation and accumulation of 
keratin debris and expanding of cholesteatoma (Olszewska et al. 2006). The presence of 
CSOM or adhesive otitis media with or without TM perforation predisposes to the 
development of cholesteatoma (Bluestone and Klein 1995), as do traumatic or iatrogenic 
perforations of the TM (Buckingham 1981, Al Anazy 2006, Persaud et al. 2007). 
The cause of congenital cholesteatoma remains somewhat controversial, as well. The two 
main hypotheses are the epithelial rest and invasion theories (Kazahaya and Potsic 2004). 
Findings of epithelial rests in the anterosuperior quadrant of the middle ear, and DNA 
differences found between acquired and congenital cholesteatoma support the epithelial rest 
theory (Karmody et al. 1998, Kojima et al. 2001), whereas evidence for the invasion theory 
suggests a misdirection of migrating ectodermal cells from the developing EAC (Aimi 1983, 
Kazahaya and Potsic 2004). The original criteria for congenital cholesteatoma were the 
presence of a white “pearl” behind an intact TM without history of perforation, otorrhea, and 
otologic surgery, but later, a history of acute otitis media, otitis media with effusion, and 
otorrhea have also been included (Koltai et al. 2002, Nelson et al. 2002). 
 2.1.4  Clinical course 
COM leads to a conductive and—in some cases also sensorineural—hearing loss in that ear. 
Furthermore, chronic inflammation and infection can corrode the mucosa and bony structures 
of the middle ear and contribute to the formation of a middle ear cholesteatoma (Bluestone 
and Klein 1995, Cummings et al. 1998). In CSOM, otorrhea through a perforated TM is often 
present, and otalgia may occur. Labyrinthitis as a consquence of chronic middle ear infection 
is possible, and more rarely, serious complications, such as acute mastoiditis, petrositis, sinus 
thrombosis, or intracranial infections occur (Leskinen and Jero 2005, Hafidh et al. 2006, 
Smith and Danner 2006). In adhesive otitis media, aeration of the middle ear is prevented by 
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obstruction or dysfunction of the ET, which leads to retraction of the TM, collapse of the 
tympanum, and conductive hearing loss of varying degrees (Bluestone and Klein 1995). 
A prograding middle ear cholesteatoma causes hearing loss (either conductive or combined), 
destroys its surrounding structures, and may, if not treated, invade the petrosal part of the 
temporal bone, facial canal, and intracranial space. Consequently, petrositis, paresis of the 
facial nerve or other cranial nerves, intracranial infection, or trauma to the intracranial 
structures may follow. A labyrinthine- or cerebrospinal fluid fistula may also develop 
(Cummings et al. 1998, Kazuharu et al. 2005, Smith and Danner 2006).
2.1.5  Diagnosis and treatment 
Diagnosis of COM is based on the clinical picture. Disease severity can be assessed by 
audiograms, sonotubometry, and radiological examinations (mainly CT). In CSOM, bacterial 
culture of middle ear secretion is a good diagnostic tool when planning treatment with 
antibiotics. CSOM is relatively resistant to nonsurgical treatment, but oral as well as topical 
antibiotics may be useful. The best response to otorrhea has been with the use of topical 
antibiotics (Verhoeff et al. 2006). However, medication often provides only temporary relief 
of symptoms. Surgical treatment of COM consists of tympanomastoidectomy followed by 
reconstruction of the middle ear (Bluestone and Klein 1995, Brackmann et al. 2001). The 
decision for surgical treatment has to be based on careful evaluation of each patient’s 
individual situation. Youth, good overall health, or systemic diseases requiring careful 
elimination of infectious foci favor surgery, whereas risk factors for operative treatment and 
anesthesia such as high age and certain diseases speak in favor of follow-up and conservative 
care.
Diagnostic guidelines for cholesteatoma are similar to those for COM. Clinical examination 
of the ear is most important with suspected cholesteatoma based on patient’s history and 
symptoms (history of COM, hearing loss, otalgia, otorrhea). Cholesteatoma may long remain 
asymptomatic. Intensive retraction of the pars flaccida and a white mass visible in perforation 
of the TM or in the middle ear through an intact TM are signs pathognomonic of 
cholesteatoma (Palva 1990, Bluestone and Klein 1995). Sometimes it is necessary to first treat 
the overlying infection in order to examine the ear properly. The ultimate diagnosis may also 
remain to be defined during surgery. Imaging of the ear with CT provides valuable 
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information on extent of the disease and helps with treatment planning (Maroldi et al. 2001). 
MRI is sometimes needed for differential diagnostics, for instance, for to distinguish 
cholesteatoma from cholesterol granuloma (Kösling and Bootz 2001, Williams and Ayache 
2004). Treatment of the cholesteatoma is in most cases surgical. Radical surgery and a long 
postoperative follow-up are usually mandatory. High age and other risk factors for anesthesia 
or surgery, combined with rather limited disease, argue for conservative treatment. 
2.2  SURGICAL TREATMENT OF CHRONIC OTITIS MEDIA AND
CHOLESTEATOMA
2.2.1  Surgical approach and eradication of the disease 
In the case of CSOM, a tympanomastoidectomy is first performed, which gives the surgeon a 
direct view of the mastoid and middle ear. During the tympanomastoidectomy, all the 
diseased bone and mucosa in the mastoid area are removed. Thereafter, the inflamed mucosa 
and debris in the middle ear are carefully stripped away (Cruz et al. 2003). Finally, 
reconstruction of the tympanic cavity, the auditory ossicular chain, and the TM will take place 
to the extent needed (Hüttenbrink 1994, Brackmann et al. 2001). Adhesive otitis media is a 
surgically difficult disease entity. Several different tympanoplasty techniques have been 
described to restore an air-filled and functional tympanic cavity, most of them using cartilage 
chips as reconstruction material (Hüttenbrink 1994). However, if the ET is permanently 
obstructed and dysfunctional, the results of surgical treatment attempts are often poor. 
The surgical approach to a cholesteatoma depends on the size and location of the diseased 
area. With small, epitympanic cholesteatomas, a transcanal atticotomy may be sufficient to 
eradicate the disease if it provides a direct, good visualization of the operative field (Palva 
1993). In atticotomy, an endaural incision is made, a tympanomeatal flap is formed, and 
sufficient bone between the EAC and the epitympanum (atticus) is drilled away to visualize 
the cholesteatoma. Subsequently, the cholesteatoma and all the diseased tissue is dissected 
from the epitympanum and removed, the epitympanic bony defect is reconstructed with 
cartilage or bone, and the tympanomeatal flap is repositioned. Reconstruction of the TM is 
executed when necessary (Palva 1987b, Brackmann et al. 2001).
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With larger cholesteatomas extending towards the hypotympanum or medially, a canal wall-
up (CWU) or canal wall-down (CWD) tympanomastoidectomy is required to reach and 
visualize the whole diseased area (Palva 1993). With the CWD technique, the entire posterior 
bony wall of the EAC is removed, resulting—if reconstruction of the wall will not be 
performed (radical operation)—in an open cavity postoperatively. In the modified radical 
operation, the posterior wall will be reconstructed (Black 1998, Mukherjee et al. 2004).
With the CWU technique, the posterior wall will not be removed, and the approach to the 
middle ear may or may not involve the facial recess (Brackmann et al. 2001). After removal 
of the cholesteatoma, the tympanic cavity, the auditory ossicular chain, and the TM can be 
reconstructed either primarily or later in the second-look operation (Kim et al. 2006). The 
advantages and disadvantages of the CWD- and CWU techniques are in Table 1. The choice 
between these techniques can be made either preoperatively or intraoperatively.
2.2.2  Reconstruction
After removal of diseased tissue from the middle ear, reconstruction of the auditory ossicular 
chain is often essential for maintenance or improvement of hearing. It is equally important to 
be able to reconstruct the tympanic cavity and the level of the TM in such a way that the 
tympanum will not totally collapse over time, which in turn would result in adhesive otitis 
media, conductive hearing loss, and increasing risk for a recidive cholesteatoma (Cummings 
et al. 1998, Brackmann et al. 2001). In cholesteatoma surgery, the reconstruction may be left 
to the second-look operation. Furthermore, obliteration of the radical cavity (Palva 1979), 
reconstruction of the posterior wall of the EAC, and meatoplasty after a CWD operation are 
usually added to the final procedure, if needed. 
In surgery for CSOM, removal of the inflamed mucosa and of possible granulation or polyps 
of the middle ear followed by myringoplasty may be sufficient, if the auditory ossicular chain 
is intact. In the case of a disrupted, partially absent, or ossified chain, the chain must undergo 
reconstruction. Autologous bony grafts are recommended as the approach, but lack of 
appropriate reconstruction material may become a problem. If no autograft columella is 
available, biomaterial implants are an option (Brackmann et al. 2001). 
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In cholestetoma surgery, the challenges of reconstruction increase in proportion to the 
radicality of the operation (Table 1). On the other hand, a second-look operation is sometimes 
needed after CWU, which in turn is not usually the case after CWD. If the destruction in the 
middle ear caused by the cholesteatoma has been extensive, the procedure of choice is CWD 
(Palva 1990). Reconstruction of the tympanum after CWD is difficult and—even if 
successful—results in minitympanum and poorer hearing than after CWU (Palva 1987a). The 
ossicular chain is most often corroded by cholesteatoma and therefore partly or in some cases 
even totally absent and has to be reconstructed. Again, autologous grafts are used initially 
(Palva 1990), but biomaterials also serve (Brackmann et al. 2001). If the radical cavity will be 
obliterated and the posterior wall of the EAC reconstructed, reconstruction material may be 
insufficient (bone chips and paté; Palva 1993), especially if most of the bone tissue drilled 
away was diseased. The advantages of the reconstructed posterior wall—compared to an open 
radical cavity—are the better circumstances for cleaning and examination of the cavity during 
the postoperative follow-up in addition to avoidance of meatoplasty (Takahashi et al. 2007). 
Use of the musculoperiosteal flap (Palva´s flap) supports the reconstructed and obliterated 
wall (Palva and Mäkinen 1979) and, in the case of radical cavity, makes the cavity easier to 
clean postoperatively.
2.2.3  Implant materials 
In reconstruction of the auditory ossicular chain and the TM, autografts are usual, if available 
(Palva 1987b, Brackmann et al. 2001). The primary goal is to remodify the incus to create a 
short or a long columella, depending on the clinical status of the stapes. In the former, the 
remodified incus will be placed between the malleus and stapes head, in the latter case, 
between the malleus and stapes footplate. If the remnants of the incus cannot be utilized, 
cortical bone with tragal cartilage (against the tympanic membrane) can serve, especially in 
cholesteatoma surgery, where disease may have destroyed or contaminated the whole 
ossicular chain. Reconstruction of the TM requires mostly autologous fascia or cartilage 
(Palva 1987b, Brackmann et al. 2001). 
If the malleus is intact, but the incus is not usable, several biomaterials are available. The 
longest used implant material with excellent biocompatibility, hydroxyapatite, has been in use 
since the early 1960s with good results (Grote 1990 and 1998, Brackmann et al. 2001). In the 
development of hydroxyapatite prostheses, a milestone in 1996 was introduction of the 
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HAPEX prosthesis. In this application, a hydroxyapatite-reinforced polyethylene composite 
cuff or shaft is attached to the dense hydroxyapatite body, allowing the surgeon to 
intraoperatively adjust the length and shape of the prosthesis more easily than those of a 
prosthesis made of pure hydroxyapatite (Brackmann et al. 2001). 
Alternatively, a titanium partial ossicular replacement prosthesis (PORP) or a total ossicular 
replacement prosthesis (TORP) with a cartilage graft is an adequate choice (Neumann et al. 
2003, Fisch et al. 2004, Truy et al. 2007). The broad base of a PORP or a TORP contacts the 
TM or malleus handle (via the cartilage graft) and extends either to the head of the stapes 
(PORP) or directly to the footplate (TORP), replacing part of the ossicular chain. Titanium 
prostheses have proven safe and stabile implants with low complication rates and good 
hearing results (Dalchow et al. 2001, Fisch et al. 2004). 
When reconstructing the posterior wall of the EAC and obliterating the radical cavity, use of 
bone (chips and paté) and fascia is advisable (Palva 1993). Furthermore, the radical mastoid 
cavity can be partially filled with and the reconstruction supported posteriorly by a 
musculoperiosteal flap (Palva and Mäkinen 1979). In the case of a large cavity or lack of bone 
paté, porous hydroxylapatite ceramic may be one option (van Blitterswijk and Grote 1990, 
Grote 1998, Takahashi et al. 2007). The decision as to reconstruction and implant materials is 
based on the clinical situation, on intraoperative findings, and on the patient’s individual 
needs (Black 1998, Cummings et al. 1998, Brackmann et al. 2001). 
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Table 1.  Advantages and disadvantages with canal wall up (CWU) and canal wall down 
(CWD) procedures (Palva 1987a and 1993, Cummings et al. 1998, Brackmann et al. 2001). 
 Advantages  Disadvantages 
CWU  - level of tympanic
 membrane easier to reconstruct 
 - postoperatively aerated
 tympanum more likely achievable
 - absence of problems caused by 
 excavation of radical cavity 
 - residual / recurrent cholesteatomas
 more likely (25%) 
 - problems with surgical control
 over facial recess and sinus
 tympani 
 - second-look operation sometimes
 necessary
CWD  - residual or recurrent
 cholesteatoma easier to observe 
 - recurrences rare (up to 10%) 
 - surgical control of facial recess
 and sinus tympani areas 
 - minitympanum postoperatively 
 - problems with reconstruction 
 - poorer hearing result 
 - cavity-cleaning problems 
2.3  MEDICAL BIOMATERIALS AND BACTERIAL ADHERENCE 
2.3.1  Definitions and background 
Biomaterials and medical implants made of biomaterials are synthetic or nature-derived 
products to be used in contact with tissue, blood, or tissue fluids for prosthetic, diagnostic, or 
therapeutic purposes. A medical implant must be used in such a way that it does not interfere 
with the vital functions of the host organism (Törmälä et al. 2003). Based on their chemical 
composition, biomaterials can be divided into metals, polymers, ceramics, composites, and 
materials of biological origin (Törmälä et al. 2003). The division can also be made according 
to the reactivity of the material surface: 1) almost inert materials with smooth surfaces, 2) 
almost inert materials with porous surfaces, 3) materials with chemically reactive surfaces, 
and 4) resorbable materials (Hench and Ethridge 1982, Gross and Strunz 1985).
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Polymeric biomaterials can be divided into three groups: biostabile, bioabsorbable 
(biodegradable or resorbable), and partially biodegradable. Ideal biostabile polymers are 
physiologically inert, cause a minimal response in the host tissue, and maintain their qualities 
for years or decades in vivo, whereas resorbable materials will be gradually degraded by the 
activity of the host tissue and by purely physicochemical reactions (Törmälä et al. 1998). 
Biodegradable materials are the best alternative in situations requiring temporary implant 
treatment. The main demand for a resorbable material and its degradation products is good 
biocompatibility. Furthermore, in the beginning of the healing process they should retain the 
tissue fixation required, and during degradation, all mechanical stress should gradually be 
shifted to the healing tissue. If no serious complications occur, such as resistant postoperative 
infection, no need will arise for a removal operation. Furthermore, after complete resorption, 
the risk for complications is considerably diminished (Törmälä et al. 1998).
Most biomaterials cause non-specific tissue reactions around the implant. In clinical medicine 
this phenomenon is to some extent acceptable—sometimes even desirable (Ratner 1993). 
Biocompatibility is the term to describe the likelihood of a material to induce a non-specific 
tissue response in a biological environment, e.g., inflammatory and foreign body reactions 
(Williams 1989, Ratner 1993); in the case of poor biocompatibility, these reactions are severe. 
Furthermore, bacterial adhesion to a biomaterial may cause a biomaterial-centered infection 
leading to poor tissue integration or poor compatibility of the implant (Gristina 1987). A 
biomaterial with good biocompatibility induces at most a mild reaction. If the reaction results 
in fibrosis, the implant material is classified as biotolerant. In in vivo conditions, a material 
may form a direct bond to the bone or cartilage; then it is called bioinert (as with titanium). 
Some materials with chemically reactive surfaces can evoke a tissue response that leads to 
integration with bone (as with bioglass); these materials are called bioactive (Törmälä et al. 
2003).
2.3.2  Biofilm formation 
According to Costerton et al. (1995), “Biofilms are defined as matrix-enclosed bacterial 
populations adherent to each other and/or to surfaces or interfaces.” A biofilm consists of 
bacteria or fungi and their extracellular matrix, which together form a microenvironment that 
essentially differs from the environment of free microbes. Biofilm usually comprises many 
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species of microbes, but it can also comprise a single species (Costerton et al. 1999). Biofilm 
microbes do possess a phenotype, metabolism, and a division rate different from those of 
planktonic counterparts (Costerton et al. 1995, Lynch and Robertson 2008). Partly due to their 
reduced activity, biofilms are very resistant to antiobiotic treatment and to the host’s immune 
system (Stewart and Costerton 2001, Lynch and Robertson 2008). Numerous activities 
maintain or strengthen the structure and function of these micro-ecosystems, such as 
interchange of plasmids between the bacteria. Recent studies have indicated that controlled 
death and lysis of bacterial cells also play an essential role in the formation and stability of the 
biofilm (Bayles 2007).
With regard to bacterial biofilms, adherence of bacteria to a surface is the first step in biofilm 
formation (van de Belt et al. 2001, Palmer et al. 2007). Thus, microbial adhesion to the 
surface of a medical implant may lead to biofilm formation and chronic infection, which in 
turn leads to increased postoperative morbidity and mortality, and often requires removal of 
the implant (van de Belt et al. 2001, Darouiche 2004, Kojic and Darouiche 2004, Pawlowski 
et al. 2005, Lynch and Robertson 2008). Furthermore, strong evidence exists for bacterial 
biofilms’ being a major factor in some chronic implant-free infections in the head and neck 
area, such as CSOM (Hall-Stoodley et al. 2006, Post 2001), chronic tonsillitis (Chole and 
Faddis 2003, Post et al. 2004 and 2007) and rhinosinusitis (Sanclement et al. 2005), and 
infected cholesteatoma (Chole and Faddis 2002). 
2.3.3  Implant surface characteristics with reference to bacterial adherence 
The material-dependent factors that influence bacterial adhesion to a biomaterial surface are 
the chemical composition of the material, the charge and hydrophobicity of the surface, and 
the physical configuration and roughness of the surface. Metal and glass surfaces are 
negatively charged and hydrophilic, while polymers are less electrostatically charged and are 
hydrophobic (An and Friedman 1998). Surface roughness has been considered an important 
factor in bacterial adherence (van de Belt et al. 2001), with several attempts at explanations as 
to why bacteria prefer to adhere to rougher surfaces (Scheuerman et al. 1998), but the 
literature provides somewhat contradictory evidence, and it seems obvious that this topic as 
well as the influence of charge and hydrophobicity are complicated and not yet fully 
understood (Hogt et al. 1985, Verheyen et al. 1993, An and Friedman 1998, van de Belt et al. 
2001, Emery et al. 2003, Katsikogianni and Missirlis 2004, Palmer et al. 2007). Evidence is, 
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however, strong that surfaces with irregularities and grooves promote more bacterial adhesion 
and biofilm formation than do smooth surfaces (McAllister et al. 1993, Quirynen et al. 1993, 
Verheyen et al. 1993, Scheuerman et al. 1998), presumably resulting from greater surface area 
and more sheltered sites for microbial colonization. The physical configuration of a material 
surface is a complicated 3-dimensional parameter related to surface ultrastructure and can be 
routinely evaluated by scanning electron microscopy (An and Friedman 1998); hence, it 
differs from surface roughness, which is simpler and detectable under light microscopy. 
Configuration indicates morphological description (for instance: a porous or a monofilament 
surface). The effect of physical configuration on bacterial adherence has been established for 
instance with dental materials, in which infection rates at the implant site have been much 
higher with porous than with dense implant materials (Merritt et al. 1979). 
2.3.4  Bacterial adherence to biomaterial surfaces
In addition to these material-dependent factors influencing the bacterial adhesion process are 
environmental factors and bacterial properties unique to different species (An and Friedman 
1998, van de Belt et al. 2001, Katsikogianni and Missirlis 2004). In general, the theory is that 
bacteria with hydrophobic properties prefer hydrophobic surfaces, and those with hydrophilic 
qualities prefer hydrophilic surfaces (An and Friedman 1998), but contradictory data and 
exceptions to this rule exist, as well (Chu and Williams 1984, Hogt et al. 1985, Verheyen et 
al. 1993, van de Belt et al. 2001, Karakeçili and Gümü derelio lu 2002, Emery et al. 2003).
Bacterial adhesion to surfaces and interfaces in vivo is, all in all, a very complicated process 
with numerous intervening factors. Their contribultion will depend, for instance, on the 
surrounding media, tissue-specific factors, bacterial concentration and flow, and temperature 
(Gristina 1987). Furthermore, unique surface characteristics and the behavior of differing 
bacterial species and strains do have their individual impact on adherence (An and Friedman 
1998, Palmer et al. 2007). Concentration of antibiotics in the surrounding tissue and 
immunological mechanisms of the host also influence the adhesion (Gristina et al. 1985 and 
1987, Lynch and Robertson 2008). After exposure to an in vivo environment, the implanted 
biomaterial becomes covered with proteins and other macromolecules within seconds, well 
before the appearance of the first micro-organisms. This adsorbed coverage, called 
“conditioning film,” can alter surface properties of the biomaterial to be more or less 
favorable to bacterial adhesion (van de Belt et al. 2001). In fact, the adhering microbes rarely 
attach to a pure biomaterial surface in vivo, but to this conditioning film. They can migrate to 
31
the surface by various transport mechanisms such as diffusion, convection, or sedimentation 
(van de Belt et al. 2001, Palmer et al. 2007). 
Initial bacterial adhesion to a substratum, according to one major theory, results from a 
combination of attractive Lifshitz-Van der Waals forces, attractive or repulsive acid-base 
interactions, and generally repulsive electrostatic interactions (van de Belt et al. 2001, Palmer 
et al. 2007). Consequently, some evidence suggests that the hydrophobicity of biomaterial 
surfaces determines which proteins will adsorb to the surface from the biological 
surroundings. Surface hydrophobicity would thus be one of the major factors to control 
bacterial adhesion to conditioning films. For example, hydrophobic biomaterials used in the 
human oral cavity and in the oropharynx have been found to gather more biofilm than do 
hydrophilic ones (Quirynen et al. 1988, Everaert et al. 1997). However, in some studies, 
surface hydrophobicity has little or no effect on bacterial adhesion (Karakeçili and 
Gümü derelio lu 2002, Palmer et al. 2007). The initial adhesion of bacteria is reversible. This 
reversible attachment may, however, turn irreversible through firm anchoring caused by 
production of exopolymers that can cover the biofilm to form a so-called “glycocalyx.” This 
term indicates the assembling of glycoproteins onto the biomaterial (Gristina and Costerton 
1985), and in addition to anchoring the biofilm, the glycocalyx protects the bacteria against 
antibiotics and host defence mechanisms (Brown et al. 1988, van de Belt et al. 2001, Palmer 
et al. 2007) 
 2.3.5  Prevention of bacterial adherence 
For decades, a great amount of work has been devoted to exploring methods for preventing or 
reducing bacterial adherence to medical implants. Numerous procedures have emerged, and 
further research uses new technologies and materials. Coating the implant surface with 
substances of an anti-adherent nature or treating the surface with certain processes will 
considerably inhibit bacterial adhesion (von Eiff et al. 2005a, Qiu et al. 2007). Furthermore, 
implants can be impregnated with antimicrobial agents (Cormio et al. 1997, Multanen et al. 
2000a, von Eiff et al. 2005b, Darouiche et al. 2007, Darouiche 2007), or biodegradable 
implants may release antibiotics during degradation (Niemelä et al. 2006). The material itself 
may also be selected for specific purposes based on its known anti-adhesive properties (von 
Eiff et al. 2005b). The aim of anti-adhesive methods is to change the surface characteristics of 
the biomaterial—mainly charge and hydrophobicity—in order to make it more undesirable for 
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bacteria to adhere to. Because of the complexity of the adhesion process, especially the 
species-dependent behavior, we have no exact rules or schemes that would be generally 
applicable to all materials and bacteria. 
Ionizing of otologic implant material surfaces (fluoroplastic and silicone) has been effective 
in preventing bacterial adhesion and biofilm formation by Staphylococci and Pseudomonas
aeruginosa in vitro (Biedlingmaier et al. 1998), and by Staphylococcus aureus in vivo (Saidi 
et al. 1999). Treating silicone tympanostomy tubes with silver oxide has reduced 
postoperative otorrhea (Chole and Hubbell 1995), but this method could not inhibit bacterial 
adherence in the study by Biedlingmaier et al. (1998), who concluded that ionized 
fluoroplastic was the most effective combination against bacterial adherence. Saidi et al. 
(1999) found no biofilm inhibition in vivo on silver oxide-impregnated tympanostomy tubes; 
in this setting, ion-implanted silicone was superior to non-treated and silver-oxide treated 
fluoroplastic tubes. Based on their results, this group also suggested that in prevention of 
persistent otorrhea, adherence characteristics of the tube material may be more important than 
antibacterial coatings. In short, bombarding of the tympanostomy tube surface with ions 
seems to be a relatively effective method for preventing or inhibiting bacterial adherence, 
whereas coating the surface with silver oxide provides somewhat contradictory results. On the 
other hand, Lundeberg (1986) showed a decrease in catheter-associated urinary tract 
infections with silver oxide-coated catheters. Multanen et al. (2000b) found that coating PLA 
urological stents with silver nitrate prevented bacterial adherence to the stents in vitro; the 
effect was tested with uropathogenic bacteria, including Pseudomonas aeruginosa.
2.3.6  Albumin coating 
Serum or tissue proteins are known to have interactions with bacteria and an influence on 
bacterial adhesion, for instance to biomaterials, in either binding to the material surface or to a 
bacterial surface, or in being present in the liquid medium during the adhesion process (An 
and Friedman 1998). These proteins can enhance or inhibit bacterial adhesion, depending on 
the protein itself and the binding target (material surface, bacterial surface, or both), and they 
also may act as mediators in the binding process between bacteria and surfaces (Kuusela et al. 
1985, Cunliffe et al. 1999, Štyriak et al. 1999). The bacteria and proteins bind to each other 
mostly with specific ligand- and receptorlike interactions, and the proteins may change the 
chemical properties of the bacterial surface as a result. When binding to biomaterial surfaces, 
33
proteins can change the surface characteristics of the substratum—for instance, the
hydrophobicity that is thought to be an important factor in bacterial adherence—and thus 
either promote or inhibit bacterial attachment (Hogt et al. 1985, An and Friedman 1998, 
MacKintosh et al. 2006). 
Albumin is an essential plasma protein, the antiadherent nature of which has been known for 
decades (Packham et al. 1969), and the literature provides several studies showing the 
inhibitory effect of albumin coating on bacterial adherence to bioimplant surfaces in vitro 
(Zdanowski et al. 1993, Keogh and Eaton 1994, An et al. 1996), and its effect in reducing 
postoperative infections in vivo (An et al. 1997). Furthermore, some evidence indicates that 
albumin coating of vascular prostheses, dialysis membranes, and artificial heart valves could 
have beneficial effects due to such a coating’s being antiadhesive and antithrombogenic 
(Remuzzi and Boccardo 1993, al-Khaffaf and Charlesworth 1996, Hyde et al. 1999). Coating 
of tympanostomy tubes with HSA has proven effective in preventing early postoperative tube 
occlusions and undesirable adhesion of proteins and other material to the tubes (Kinnari et al. 
2001, 2003, 2004, 2005), although no significant difference between HSA-coated and 
uncoated tubes emerged in a long-term follow-up of postoperative sequelae (Kinnari et al. 
2007). Coating a medical implant with HSA seems to be a safe method. One follow-up study 
of 200 patients with albumin-coated vascular grafts (al-Khaffaf and Charlesworth 1996) 
uncovered no disadvantages. Commercially available HSA is manufactured from donor 
blood, and during this process it is heated at 60°C for hours, which causes inactivation of 
hepatitis viruses. In general, the safety of HSA use in medical care has been very high (Tullis 
1977, Erstad 1996). 
In its native state, albumin carries a strong net negative charge that makes it move rapidly in 
electrophoretic fields, but despite this negative charge, it can bind reversibly to both cations 
and anions (Tullis 1977). Because of albumin’s strong binding affinity, biomaterial surfaces 
can be easily covered by a durable albumin coat (An et al. 1996, Kinnari et al. 2003). 
Although the mechanism of albumin’s inhibitory effect on bacterial adhesion is unclear, it has 
been assumed to be based on the changes induced in the hydrophobicity and charge of the 
substratum surface (Hogt et al. 1985, An and Friedman 1998). As established by scanning 
electron microscopy (Kinnari et al. 2003), after albumin coating, the roughness of the surface 
has also been found to decrease, which presumably makes the biomaterial surface less 
favorable for bacterial adhesion. 
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2.3.7  Silicone and titanium as otologic implant materials 
In ear surgery, silicone and titanium have long served as implant materials. The most common 
application is the tympanostomy tube that generally consists of silicone or titanium 
(Bluestone and Klein 1995). Silicone sheets have been useful to line the walls of the 
tympanum in the surgery for CSOM to prevent development of adhesive otitis media 
postoperatively (Brackmann et al. 2001), and silicone bands are sometimes used to stabilize 
middle ear prostheses (Vincent et al. 2005). Titanium has clinically proven to be an excellent 
auditory ossicular replacement material with good biocompatibility, stability, and low 
complication rates (Brackmann et al. 2001, Dalchow et al. 2001, Yung 2003, Fisch et al. 
2004), and it has also been successful in reconstruction of postauricular mastoidectomy 
defects (Jung and Park 2004).
2.4  POLYLACTIC- AND POLYGLYCOLIC ACID-BASED COPOLYMERS 
2.4.1  Polylactic-, polyglycolic-, and polylactic-glycolic acid
The biodegradable polymers polylactic acid and polyglycolic acid are derived from the cyclic 
dimers (lactide and glycolide) by polymerization. These polymers are degraded by hydrolysis 
and enzymatic activity in vivo to monomers (lactic- and glycolic acid) and finally to the end 
products carbon dioxide and water. Pure PLA degrades and loses its strength very slowly due 
to its crystallinity and hydrophobicity. Lactic acid exists in two stereoisomeric forms, L- and 
D-lactic acid, and the stereocopolymers of PLA (derivatives of L-, D-, or DL-lactides) 
degrade more rapidly than does pure PLA, due to their lower crystallinity (Waris et al. 2004). 
Pure PGA is a hard, crystalline polymer insoluble in most common polymer solvents that has 
a high initial strength which nevertheless diminishes rapidly in vivo within a few weeks, due 
to its susceptibility to hydrolysis (Törmälä et al. 1998). In addition, rapid hydrolysis of PGA 
releases large amounts of glycolic acid, which can lead to decreased biocompatibility 
(Böstman and Pihlajamäki 2000, Waris et al. 2004). 
Polylactic-glycolic acid is a copolymer synthesized from the corresponding homopolymers 
(PLA and PGA). Combining PLA and PGA at different ratios allows degradation speed and 
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other biomechanical characteristics of the PLGA to be regulated. The more PGA that PLGA 
contains, the faster it is degraded and the greater is its initial strength (Park 1995). PLGA 
copolymers have relatively low crystallinity, and their physical properties are halfway 
between those of pure PLA and of PGA. For example, a PLGA 80/20 (80% PLA, 20% PGA) 
copolymer is substantially amorphous and maintains its mechanical strength for 6 to 8 weeks 
in vivo (Waris et al. 2004). Subsequently, complete absorption occurs in 1 to 2 years (Eppley 
and Reilly 1997, Tiainen et al. 2004, Landes et al. 2006a). Several commercially 
manufactured PLGA products have been precisely engineered for specific uses, 
simultaneously utilizing the possibility to influence with the copolymer ratio the degradation 
time and mechanical properties. In recent decades, PLA- and PGA-copolymers have been 
under intensive bioimplant- and tissue engineering research due to their innumerable potential 
applications and modifications. Polymer matrices can be reinforced with molecules or 
bioabsorbable fibers to enhance their mechanical strength, moldability, and elasticity 
(Törmälä et al. 1998, Lewandrowski et al. 2000). Furthermore, they can serve as porous 
scaffolds or as carriers of cells, extracellular matrix components, or bioactive agents (section 
2.4.4).
2.4.2  Biocompatibility 
The biocompatibility of an implanted material is a dynamic process that involves the effect of 
the host on the material and of the material on the host. Implantation of any synthetic material 
induces a wound-healing mechanism which is characterized by an inflammatory reaction 
(Merchant 1989). This non-specific inflammatory response may involve a foreign body 
reaction or fibrosis (Törmälä et al. 2003). Some characteristics of the implant material may 
also promote bacterial adhesion to its surface, which in turn may predispose to postoperative 
implant infection and lead to poor tissue integration and compatibility (Gristina 1987). 
The PLA- and PGA-derived implants have a history of more than 30 years of clinical use and 
have been proven safe and biocompatible materials in the majority of clinical and 
experimental studies (Böstman et al. 1995, Kallela et al. 1999, Suuronen et al. 2004, Waris et 
al. 2004, Landes et al. 2006b). Clinically significant complications range from less than 1% 
up to 10% of the patients, the average, in the large study groups, being around 5%. The peri-
implant tissue response seems to continue as long as the degradation continues. It involves 
slightly elevated leukocyte activity near or on the surface of the degrading material, plus 
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fibroblast activity with production of collagen and other connective tissue proteins in the 
outer zone of the interface area (Santavirta et al. 1990, Kontio et al. 1998 and 2005, 
Pihlajamäki et al. 2006), the latter phenomenon indicating fibrous capsule formation around 
the implant. These histological findings are similar to those seen during wound healing. In a 
large retrospective study of 2528 orthopedic patients (Böstman and Pihlajamäki 2000), 
adverse reactions around the implant included a sterile inflammatory reaction with foreign-
body giant cells. In 4.3% of these patients the response was clinically significant, including 
erythema and discharge, sinus formation, and osteolytic changes at the implant site. The 
reactions ranged from mild to severe, and four patients developed severe osteoarthritis. 
Complications were established essentially more with PGA implants (5.3%, n=107) than with 
PLA implants (0.2%, n=1). 
In dog ureters, PLA induces only minimal wall edema, epithelial hyperplasia and destruction, 
and an inflammatory cell reaction in situ. These reactions subside after the degradation of the 
stent (Lumiaho et al. 2000). Biocompatibility of a barium sulfate-blended (X-ray-positive) 
PLA stent in rabbit urethras was good (Isotalo et al. 1999). Multanen et al. (2002) also 
reported the good biocompatibility of a urethral PLA stent in rabbits. With experimental 
endotracheal PLA- and PLGA stents, the findings in pigs and rabbits have included some 
mucosal hyperplasia, epithelial ulceration, and inflammatory reactions around the implant, but 
good overall biocompatibility of the materials in the trachea. Scanning electron microscopy 
studies have revealed re-epithelization with ciliated cells of the tracheal wall over the implant 
(Korpela et al. 1998 and 1999, Robey et al. 2000a, Nalwa et al. 2001). External tracheal 
PLGA stents in a rabbit model (Robey et al. 2000b) have induced granulomatous 
inflammation and fibrosis outside the tracheal lumen; in some of these animals 
endotracheally, subepithelial edema was evident as well as foci of acute inflammation. Re-
epithelization of the interior surface was complete in all animals. PLGA has also been used 
successfully in rabbit laryngotracheal reconstruction (Klein et al. 2005) and vocal cord 
medialization laryngoplasty (Dufresne and Lafreniere 2000). 
PLA-composed vascular stents have proven highly biocompatible in experimental animal 
studies. Histological findings regarding this implant have been quite similar to those 
mentioned, including infiltration of chronic inflammatory cells, a mild foreign body reaction, 
and fibrosis (Hietala et al. 2000, Vogt et al. 2004, Uurto et al. 2007). These stents have also 
been tested as drug carriers. First, the implant is coated by the drug, or the drug is 
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incorporated into the implant material by processing (Blindt et al. 1999). Then the drug is 
delivered locally during the implant degradation. Drug-release kinetics can be regulated by 
implant pore size. PLA vascular stents containing indometacin have induced less fibrosis 
(Uurto et al. 2007), and those eluting dexamethasone or paclitaxel have induced less 
neointimal hyperplasia than have the ones without the drug (Vogt et al. 2004, Uurto et al. 
2005). Overall biocompatibility of the stents has been good. Tissue engineering of 
experimental vascular grafts has involved culturing of smooth muscle cells on a PGA mesh in 
a bioreactor system (Ratcliffe 2000). After 8 weeks, the mesh was replaced by a smooth 
muscle cell medial layer. Later, epithelial cells were added to form a two-layered arterial 
graft, the applicability of which was tested in pigs; the grafts remained functioning for up to 4 
weeks.
Feenstra et al. (1984) investigated the suitability of PGA and PLA in myringoplasty in rats 
and dogs. PGA grafts proved not to be applicable for this purpose because of rapid 
disintegration of the implant into sharp needles. PLA gave satisfactory results with the rats, 
but in dogs the grafts succeeded less well, inducing a more marked inflammatory reaction 
both in the middle ear and subcutaneously. Biocompatibility of PLA in the chinchilla middle 
ear has been studied by Goycoolea et al. (1991, 1992, 1994), who also developed a new, self-
expandable PLA device for antibiotic delivery. Release of ampicillin during the implant 
degradation remained at therapeutic levels in vitro during a 3-month follow-up, and in vivo 
efficacy of this implant was evident in otitis-induced cats and chinchillas. Furthermore, the 
investigators found no inflammatory reaction from the device itself and no evidence of 
ototoxicity to the organ of Corti. They also documented biodegradation of the device in the 
chinchilla middle ear in a 3-week follow-up period.
Resorption rate and biocompatibility characteristics of PLA- and PLGA tympanostomy tubes 
in the guinea pig were determined by Massey et al. (2004). They found that PLA tubes 
remained longer in the TM than did PLGA tubes, and the biocompatibility of the 
biodegradable tubes corresponded to that of the control minigrommet tubes. Mild 
inflammatory changes in the TM occurred in all groups (including the controls), and after 
resorption of the biodegradable tubes, the TMs healed normally. The end stage of the TMs 
after healing was found to be histologically similar to that of the non-operated controls. No 
excessive tympanosclerosis or atrophy of the TMs was observable.
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2.4.3  Bacterial adherence 
Quite a few studies examine bacterial adherence to pure PLA, PGA, or PLGA surfaces. 
Polymer surfaces in general possess more hydrophobic than hydrophilic properties (An and 
Friedman 1998), and this could be assumed to enhance the adherence of many bacterial 
species to these surfaces. However, contradictory data exist on this topic, as well as data on 
some other bacterial adherence principles, as mentioned (section 2.3). 
Petas et al. (1998) studied the adherence of uropathogenic bacteria (Proteus mirabilis, 
Pseudomonas aeruginosa, Enterococcus faecalis, and Eschericia coli) to self-reinforced 
PGA- and PLA urological spiral stents in vitro. Gold, polyurethane, and latex served as 
controls. The results showed a more significant correlation between adhesion and bacterial 
type than with material tested. The authors concluded that the bacterial properties are equally 
or more important in the adhesion process than are the characteristics of the material. 
Verheyen et al. (1993) investigated the adherence of Staphylococcus aureus and 
Staphylococcus epidermidis to PLA, composite (hydroxyapatite/PLA), and stainless steel. S.
aureus adhered more to metal and composite than to pure PLA, whereas S. epidermidis
showed no preference for any of the materials tested. Chen et al. (1997), exposing collagen-, 
polytetrafluoroethylene-, and PLA membranes to oral bacterial flora, found no differences in 
bacterial adherence or antimicrobial properties between these materials. Adherence of S.
aureus, S. epidermidis, E. coli, and L. acidophilus to polymeric biomaterials, among which 
was PLGA, was explored by Karakeçili and Gümü derelio lu (2002), who concluded that the 
adhesion behavior of S. aureus and S. epidermidis was independent of the polymeric surface 
hydrophobicity, whereas less adherence of E. coli and more that of L. lactophilus occurred on 
the surfaces with the most hydrophilic properties. Bacterial adherence in this study was tested 
under static conditions and in a laminar flow cell. Ludwick et al. (2006) examined the 
adherence of S. aureus and P. aeruginosa to experimental PLA tympanostomy tubes in vitro. 
After similar bacterial incubation and conditioning of the tubes, bacterial cultures were taken 
from PLA tubes and standard fluoroplastic tubes. With both bacteria, the mean bacterial 
colony count was significantly lower for the PLA- than for the fluoroplastic tube group. The 
authors concluded that the pure PLA is bacteriostatic. However, no conclusions could be 
drawn as to mechanism of this proposed characteristic of PLA.
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In addition to the studies on bacterial adherence to pure PGA, PLA, and PLGA, a number of 
studies consider the adherence in vitro of various bacterial species to PLA-, PGA-, and PLGA 
materials which were antibiotic-blended, -releasing, or which possessed antimicrobial 
properties (silver nitrate-coated) (Cormio et al. 1997, Multanen et al. 2000a and 2000b, 
Niemelä et al. 2006). The results in general have shown a clear decrease in bacterial 
adherence to the pretreated materials in comparison to adherence to non-treated ones. 
2.4.4  Applications
Polylactic- and polyglycolic acid-based bioimplants have been successful for decades in 
CMF-, orthognathic-, and orthopedic surgery, for example as osteosynthetic plates and screws 
(Suuronen et al. 2000 and 2004, Böstman and Pihlajamäki 2000, Rokkanen et al. 2000, Al-
Sukhun et al. 2006, Landes et al. 2006), and as suture materials in all surgeries (Törmälä et al. 
1998). Furthermore, antibiotic-releasing screws have been developed to prevent or treat bone 
infections (Waris et al. 2004). In plastic surgery, PLGA plates have served for reconstruction 
of the auricle instead of a costal cartilage graft in patients with microtia (Lim et al. 2006). 
Urethral stents made of PLA, PGA, or PLGA have been in wide clinical use (Tammela and 
Talja 2003). PLA stents have also been used clinically to treat coronary artery occlusive 
disease with promising results (Tamai et al. 2000). In addition, successful reduction of 
neointimal hyperplasia and restenosis of the artery with biodegradable, drug-eluting stents has 
been documented in experimental studies (Yamawaki et al. 1998, Vogt et al. 2004, Uurto et 
al. 2005). 
Experimentally, PLA implants have protected the bone defects against invasion by 
surrounding tissues, while the defects have gradually filled with new bone tissue. Based on 
these studies, whether the pure PGA or PLA has an osteostimulatory effect on bone 
regeneration has been controversial (Giardino et al. 1999 and 2006, Gogolewski et al. 2000, 
Nordström et al. 2001, Schmidmaier et al. 2006). Bone tissue engineering and osteogenesis 
induction in vitro and in vivo have been successful with the use of composites as scaffolds 
consisting of PLA/PGA and bioceramics (bioactive glass, tricalcium phosphates, and 
hydroxyapatites) (Blaker et al. 2003, Waris et al. 2004, Hasegawa et al. 2007). Culture of 
chondrocytes on PLGA in vivo has resulted in neocartilage formation of the exact dimensions 
of the original scaffold (Baek and Ko 2006); fibroblast culture on PGA scaffold in vitro has 
also been successful (Kwon et al. 2001). Biodegradable scaffolds as well as growth factor-
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releasing degradable biomaterials are likely to come into routine clinical use (Rice et al. 2005, 
Wildeman et al. 2005). Nanoparticles as potential carriers can be designed for site-specific 
delivery of many kinds of drugs and macromolecules. During recent years, extensive 
investigations have explored the possibilities to use biodegradable polymers, especially PLA, 
PGA, and PLGA, for preparation of nanoparticles (Bala et al. 2004). The targeting capability 
of nanoparticles is, however, influenced by numerous factors in vivo requiring continuous 
research on clinical applications in this field. 
2.5  RADIOLOGICAL EXAMINATION OF THE MIDDLE AND INNER EAR 
2.5.1  Projection radiography 
Conventional projection radiography of the ear includes lateral, axial, and semiaxial 
projections. The pneumatization stage of the mastoid cells and signs of sclerosis or bone 
destruction can be evaluated to some extent (Cummings et al. 1998). Projection radiography 
has nowadays been replaced by CT, which is much more accurate and provides exact 
information on bony structures and cavities in the middle and inner ear area. 
2.5.2  Computed tomography 
CT is the initial method of choice for imaging the middle ear. The middle and inner ear 
contain many tiny and thin bony structures adjacent to air-filled spaces, for imaging of which 
CT is superior to other techniques (Williams and Ayache 2004). Clear visualization of erosion 
and destruction of bone tissue in pathological situations such as cholesteatoma or COM is 
essential for diagnostics and treatment planning. 
In acute otitis media and mastoiditis, CT shows the fluid- and debris-filled middle ear cavity 
and mastoid cells with their bony borders (Migirov 2003). Furthermore, CT is the main 
modality of choice for investigating various manifestations of COM and cholesteatoma; CT 
explores the extent of bone destruction, its relationships to the surroundings, the state of the 
auditory ossicular chain, and retractions of the TM (Maroldi et al. 2001). Temporal bone 
fractures are also revealed by CT (Casselman 1996). Because of excellent visualization of the 
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ossicular chain, CT should be chosen as the primary imaging method in diagnostics of 
conductive hearing loss. Such situations include complications of acute otitis media and 
COM, postoperative ear, trauma, and congenital bony or vascular anomalies such as persistent 
stapedial artery (Kösling and Bootz 2001, Maroldi et al. 2001, Rangheard et al. 2001, Migirov 
2003, Jain et al. 2004, Williams and Ayache 2004). In the imaging of inner ear pathology, the 
pars petrosus and certain anomalies of the temporal bone, and in differential diagnostics of 
cholesteatoma or tumors in the temporal bone area, CT may be complementary to MRI and 
vice versa (Jackler and Parker 1992, Casselman 1996, Czerny et al. 2001, Klingebiel et al. 
2002, Curtin 2003). 
CT should be performed in both axial and coronal planes either separately or by multislice 
helical (spiral) CT, in which the X-ray tube continuously rotates around the patient who is 
simultaneously being moved longitudinally. With multislice helical CT, computer data allow 
multiplanar reconstruction of images in each preferred plane (Caldemeyer et al. 1999). Slice 
thickness in the image set can be a minimum 0.5 mm, and imaging should be performed with 
a high-resolution bone algorithm. For imaging the ear, contrast agents are usually not 
necessary unless vascularised lesions (such as tumors) and anomalies, or complications of 
otitis media are suspected (Maroldi et al. 2001). The disadvantage of CT is the patient’s 
exposure to a relatively high radiation dose per examination. Furthermore, it is sometimes 
necessary to image the ear several times, e.g., pre- and postoperatively or during follow-up. 
The radiation dose acquired from CT increases cumulatively when repeated. Some 
controversy exists as to need for routine preoperative CT scanning of cholesteatoma patients 
(Watts et al. 2000, Yates et al. 2002, El-Bitar et al. 2003). However, with clinical signs of a 
complicated situation, or in the case of congenital cholesteatoma or revision surgery, 
preoperative CT examination may be advisable. 
2.5.3  Magnetic resonance imaging 
MRI is superior to CT in showing liquid-filled areas such as inner ear content and in 
resolution of soft tissues (Williams and Ayache 2004). If imaging in diagnostics of primary 
sensorineural hearing loss is necessary, MRI is the method of choice. Furthermore, suspected 
intracranial or other life-threatening complications of acute otitis media, CSOM, 
cholesteatoma, or petrositis requires use of MRI, often together with CT (Jackler and Parker 
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1992, Maroldi et al. 2001). MR angiography replaces the need for digital subtraction 
angiography (DSA) in evaluation of possible sinus and jugular vein involvement. 
MRI is useful in differential diagnostics of petrous apex lesions, cholesteatoma and its 
recurrences, granulation tissue, cholesterol granuloma, and soft tissue pathology 
(inflammation, tumors) (Jackler and Parker 1992, Casselman 1996, Kösling and Bootz 2001, 
Williams and Ayache 2004, Dubrulle et al. 2006). New sequences in MRI seem useful in 
detecting residual or recurrent cholesteatoma in postoperative follow-up (De Foer et al. 2007, 
Ketelslagers et al. 2007). In addition, MRI is recommended when exact dimensions of 
complex conditions affecting the middle ear must undergo assessment, such as extensive 
cholesteatoma and certain postoperative situations, in relation to the dura mater and 
intracranial structures (Kösling and Bootz 2001, Maroldi et al. 2001). Any interruption of the 
tegmen tympani has to be evaluated with MRI for the exclusion of meningocele or 
meningoencephalocele. MRI should also be the procedure of choice when a middle- or inner 
ear tumor (like vestibular schwannoma) or other pathology of nerve tissue or labyrinthine 
content is suspected (Czerny et al. 2001). For diagnostics of glomus tympanicum or an 
aberrant internal carotid artery, MR angiography is advisable, and jugular bulb anomalies may 
require MR venography (Maroldi et al. 2001). 
An MRI study requires use of a head coil. Images are taken in axial and coronal—in some 
cases also sagittal—planes to the hard palate, with both T1 and T2 sequences performed. Gd 
(Gadolinium)-DTPA contrast agent is given intravenously to verify eventual circulation in the 
object or to enhance contrast between the tissues when necessary (Jackler and Parker 1992, 
Maroldi et al. 2001, Williams and Ayache 2004). Avoidance of radiation exposure is the great 
advantage of MRI over CT. However, MRI has patient-dependent limitations: pacemakers 
and most of the ferromagnetic foreign bodies are not allowed; claustrophobia, lack of patient 
cooperation, and allergies to contrast agents may also limit MRI use.
2.5.4  Digital subtraction angiography
DSA plays an important role in preoperative planning when treating paragangliomas 
extending into the middle ear. DSA allows evaluation of stage and extent of tumor 
vascularisation. Furthermore, DSA and related interventional techniques play an essential role 
in successful preoperative embolization of these tumors (Maroldi et al. 2001). 
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2.6  CONE-BEAM COMPUTED TOMOGRAPHY 
2.6.1  Technical basis 
The CBCT technique was originally developed in the 1990´s for radiotherapy and vascular 
imaging applications (Saint-Félix et al. 1994, Cho et al. 1995) and was also employed in 
microtomography of small specimens used in biomedical and industrial applications (Machin 
and Webb 1994). In the late 1990´s, the technique was first applied to dental, and later to 
maxillofacial imaging (Mozzo et al. 1998, Arai et al. 1999, Hashimoto et al. 2003, Sukovic 
2003, Hintze et al. 2007). With continuous research and technical advancement of the 
equipment, new applications of CBCT are emerging. 
CBCT is based on volumetric tomography data acquired from a two-dimensional detector 
combined with a 3D X-ray beam. In the CBCT technique, a 360° rotating scan with the X-ray 
tube and the detector move around the patient’s head, which is stabilized in a head-support. 
Rotation time is between 10 and 40 s, being typically 17 s or more (Robinson et al. 2005, 
Boeddinghaus and Whyte 2007). Based on the data acquired, the computer software creates a 
3D volumetric data set that can be used to reconstruct high-resolution images in axial, sagittal, 
coronal, or modified planes (Terekado et al. 2000, Araki et al. 2004, Scarfe et al. 2006). In 
most of the commercially available machines, the patient is in a standing or sitting position 
during scanning (Fig. 1), although some equipment allows the patient to be in a supine 
position.
The field of view (FOV) of the machine depends on the model of the scanner and varies from 
3 to 20 cm in height and axial diameter (Araki et al. 2004, Robinson et al. 2005). The X-ray 
tube voltage and current can be adjusted, with different FOV modes for a specified purpose 
(e.g., facial, panoramic, and implant modes) (Araki et al. 2004). CBCT is particularly well 
suited for high contrast resolution such as imaging of bone. Due to the lower radiation dose of 
CBCT compared to conventional CT, its image noise is greater and low contrast resolution 
poorer (Robinson et al. 2005). Furthermore, X-ray scatter in CBCT limits image quality 
significantly by reducing contrast and by creating image artifacts (Siewerdsen et al. 2006). 
CBCT is therefore not yet suitable for routine diagnostic soft-tissue assessment. However, the 
latest advancements have brought new, better techniques and software algorithms for X-ray 
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scatter estimation and correction, as well as for improving contrast-to-noise-ratio (CNR) and 
contrast (Gomi et al. 2006, Siewerdsen et al. 2006, Tu et al. 2006, Graham et al. 2007). In 
addition, new techniques allow focusing the imaging—and thus the irradiation—onto the 
region of interest (ROI) only (Wiegert et al. 2005, Cho et al. 2007). The ROI may be only a 
small part of the FOV of the machine such as a small change in the object during 
interventional radiology. The ROI imaging techniques allow reduced radiation exposure to the 
patient, lesser scattering to the detector, and a potential increase in spatial resolution of the 
reconstructed images. 
The volumetric data set involves small 3D cuboid units called voxels. Each voxel represents a 
specific degree of X-ray absorption, and the size of the voxels determines the resolution of the 
image. In CBCT equipment, the voxel resolutions are isotropic. Isotropic voxels, equivalent in 
all three dimensions, result in sub-millimeter spatial resolution that is often much higher than 
in multislice CT equipment (Scarfe et al. 2006, Boeddinghaus and Whyte 2007). Minimum 
section distance can be as small as 0.08 mm in some models. Studies comparing accuracy of 
CBCT with conventional CT units have usually shown a clear advantage for CBCT in 
imaging small pathologic changes in hard tissues or implants (Hashimoto et al. 2003 and 
2007, Sukovic 2003, Winter et al. 2005, Suomalainen et al. 2008). 
Data published on the radiation dose with CBCT examination indicates that the skin and 
effective doses are considerably lower than in conventional CT imaging (Mozzo et al. 1998, 
Linsenmaier et al. 2002, Hashimoto et al. 2003, Mah et al. 2003, Sukovic 2003, Schulze et al. 
2004, Winter et al. 2005, Scarfe et al. 2006). The dose is, however, affected by many factors 
such as the settings and protocols used as well as the FOV of the equipment (Robinson et al. 
2005). In addition, with the low-dose techniques applied in conventional CT, the difference 
between radiation doses (CBCT vs. conventional CT) can be reduced (Cohnen et al. 2002, 
Suomalainen et al. 2008). Other advantages of CBCT, compared with traditional CT, include 
a lower level of metal artifacts in images and smaller, lower-priced, mobile equipment (Scarfe 
et al. 2006).
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2.6.2  Current applications 
CBCT technology has undergone significant development in the past few years, and its 
operative field is continuously expanding. Microtomography with the cone beam technique 
has been used experimentally for investigation of the bone architecture and mineralization, 
vasculature, heart valves, tumors, and for adipose tissue quantification (Machin and Webb 
1994, Robinson et al. 2005). It has also been useful in experimental endodontology. In clinical 
use, CBCT has already established its position in dental and maxillofacial imaging as an 
alternative to panoramic radiography and conventional CT (Sukovic 2003, Scarfe et al. 2006, 
Boeddinghaus and Whyte 2007). CBCT has proven very accurate in showing details of hard 
tissues in the maxillofacial skeleton and dental area. It has also been a useful tool for the 
planning of dental surgery and for evaluation of implant position and postoperative status 
(Terekado et al. 2000, Ito et al. 2001, Ziegler et al. 2002, Winter et al. 2005, Guerrero et al. 
2006, Nickenig and Eitner 2007, Suomalainen et al. 2008). Some evidence suggests that 
CBCT may be useful in evaluation of the cervical vertebrae, arteriosclerosis of the carotids, 
and the laryngeal skeleton (Heiland et al. 2007). 
The CBCT technique has been applicable to planning (with image guidance) and dose 
calculation of radiotherapies (Guckenberger et al. 2006, Morin et al. 2006 and 2007). With 
special algorithms, soft-tissue resolution has been sufficient for imaging the tumors and inner 
organs to the required extent. Results with CBCT-guided intensity-modulated radiation 
therapy have been convincing (Chen et al. 2006, Ding et al. 2007). Dietrich et al. (2006) 
investigated Linac-integrated four-dimensional cone-beam CT for on-line imaging of patients 
receiving radiotherapy. Their modified system was developed for registering of the breathing 
phase during image acquisition and for correction of artifacts caused by breathing 
movements. Based on the data acquired, a respiratory phase-correlated four-dimensional 
CBCT reconstruction was possible. 
Experimental and clinical studies on CBCT for intraoperative image-guidance and digital 
angiography have been successful. CBCT angiography has been efficient in abdominal 
interventional procedures (Hirota et al. 2006) and in chemotherapy dose-calculation for head 
and neck tumors (Kakeda et al. 2007a). Furthermore, it has been useful combined with DSA 
for imaging and transcatheter embolization in diagnosis and treatment of hepatocellular 
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carcinoma (Kakeda et al. 2007b). Yang et al. (2007) showed CBCT images of mastectomy 
specimens to have good tissue contrast, and CBCT of the breast has been anticipated as future 
technology (Van Ongeval 2007). Experimentally, CBCT has been adequate for intraoperative 
guidance of head and neck surgery, based on soft-tissue and bony anatomy visualization at 
radiation-dose levels low enough to allow repeated intraoperative imaging (Daly et al. 2006). 
Furthermore, intraoperative CBCT has proven useful and accurate in tibial plateau fracture 
reduction (Khoury et al. 2007), navigated implantation of oral implants after microsurgical 
bone transfer (Heiland et al. 2008), evaluation of sinus floor augmentation (Blake et al. 2007), 
and surgery on the frontal recess (Rafferty et al. 2005). 
Gupta et al. (2004) presented an experimental prototypical volumetric CT scanner with a flat-
panel detector suitable only for ex vivo specimens. They found this prototype to be better than 
multislice CT in revealing fine osseus structures of the temporal bone. Dalchow et al. 
(2006a,b) examined cadaver temporal bones and patients with conductive hearing loss with 
the CBCT technique. They could show precise, high-resolution, and almost artifact-free 
visualization of the alloplastic middle ear implants in the bones. They also demonstrated 
CBCT to be useful in showing the cochlear implant in normal position. Compared with 
intraoperative findings, CBCT had excellent prognostic value in patients with conductive 
hearing loss in predicting disruption or erosion of the auditory ossicular chain. Thus far, the 
literature provides no reports, however, on CBCT in routine clinical otologic imaging, and 
only a few studies on otologic CBCT. 
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AIMS OF THE STUDY 
The aims of the thesis were 
I to develop a methodology for measuring and quantifying bacterial adherence and its 
inhibition by albumin on different implant materials in vitro.
II to study the in vitro adherence to PLGA of Staphylococcus aureus and Pseudomonas
aeruginosa and its inhibition by albumin in comparison to two common otologic 
implant materials: titanium and silicone.
III to test the biocompatibility of two different PLGA materials in the middle ear.
IV to estimate the accuracy of cone-beam CT in imaging of the temporal bone in 
comparison to multislice helical CT. 
V to evaluate the suitability of cone-beam CT for imaging of an operated temporal bone 




MATERIALS AND METHODS 
4.1  BACTERIAL ADHERENCE STUDIES (I, II) 
4.1.1  Plates 
Bacterial adherence was tested on uncoated and albumin-coated titanium (I, II), silicone (II), 
and two different PLGA (II) plates. Before all the experiments, the commercially pure 
titanium plates sized 5 x 5 x 1.2 mm were polished with a silicon carbide polishing paper up 
to P 1200, after which, under light microscopy, they all had identical surface structure. In the 
first study (I), 3 HSA-coated and uncoated titanium plates were exposed to each bacterium; 
altogether titanium plates numbered 12 in this study. In the second work (II), these numbers 
were a respective 4 and 16. The silicone plates sized 5 x 5 x 0.5 mm were cut from a 
commercial silicone sheet (Silatos™, Atos Medical AB, Horby, Sweden) used in surgical 
otorhinolaryngology. Altogether 16 plates of silicone were exposed to each bacterium, 8 of 
the plates being HSA-coated and 8 uncoated. The PLGA plates were cut from sheets of two 
different commercial PLGA types to yield group A of 16 plates sized 5 x 5 x 0.75 mm 
(LactoSorb®, Walter Lorenz Surgical, Jacksonville, FL, USA) and group B of 16 plates sized 
5 x 5 x 0.6 mm (Bionx Implants Ltd., Tampere, Finland). The ratio of L-lactate to glycolic 
acid was 82% vs. 18% in group A and 80% vs. 20% in group B. The plates of both PLGA 
groups were exposed to bacteria as described above. In total, 12 plates were included in the 
first study (I) and 64 plates in the second (II). 
4.1.2  Coating of the plates with human serum albumin 
Albumin coating of the plates was performed with 1% HSA (Human Albumin SPR 40 mg/ml, 
Finnish Red Cross Blood Transfusion Service, Helsinki, Finland). The plates were incubated 
at room temperature (RT) in Eppendorf tubes overnight in 1 ml of 1% HSA per plate. The 1% 
HSA resulted from diluting 250 μl of purified HSA (40 mg/ml) with 750 μl phosphate-
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buffered saline (PBS, pH 7.4). After incubation, the unbound albumin was removed from the 
tubes by washing them three times with PBS. Thereafter, the plates were air-dried and stored.
4.1.3  Bacteria 
Culturing of the bacteria, exposure of the plates, and bacterial staining took place in the 
laboratory of the Division of Clinical Microbiology, University of Helsinki, Finland. 
Staphylococcus aureus (ATCC 25923) was cultured in Todd-Hewitt broth at 37°C overnight 
under continuous orbital shaking. The bacteria were harvested by centrifugation at 4500 g for 
10 min. at RT and washed three times with PBS for 5 min. The bacteria were suspended in 
PBS to give final concentrations of 1 and 5 × 108 colony-forming units (CFU)/ml, based on 
optical density at 600 nm. 
Pseudomonas aeruginosa (ATCC 27853) was cultured at 37°C overnight on chocolate agar 
plates made in 19 g/l Müller-Hinton II broth and 20 g/l trypticase soy agar (Becton Dickinson, 
Cockeysville, MD, USA). The bacteria were collected from the plates and suspended in PBS 
to give final concentrations of 1 and 5 × 108 CFU/ml, as confirmed by plate counts. 
4.1.4  Exposure of the plates to bacteria 
Prior to exposure, the uncoated plates were washed once with PBS. Three uncoated and three 
albumin-coated plates of titanium were incubated in each bacterial suspension at RT for 90 
min (I). In Study II, four uncoated and four albumin-coated plates of each material were 
incubated in the same manner in suspensions of both bacteria at concentration of 5 × 108
CFU/ml. Thereafter, the plates were washed three times with sterile PBS and once with 
purified water for 5 min. each to rinse away free bacteria and buffer. After this procedure, the 
plates were air-dried at RT and fixed to object glasses. 
4.1.5  Quantification of bacterial adherence 
After the bacterial contamination, all plates included in the studies were stained for 2 min. 
with acridine orange and rinsed with H2O. On each plate, 10 fields measuring 140 × 110 μm
(1300 × 1030 pixels) were viewed with the fluorescence microscope Zeiss Axioplan 2 (Carl 
Zeiss Vision GmbH, München-Hallbergmoos, Germany) at 63 × /1.25 magnification, and a 
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standard FITC filter (fluorescein isothiocyanate) was used to analyze the fluorescence in the 
field. The fields were photographed digitally with Zeiss AxioCam HRc equipment (Carl 
Zeiss). The photomicrographs were taken of identical sites on each plate. A rectangular path 
(1 × 1.5 mm) was formed around the center of the plate, and 10 photographs were taken at 0.5 
mm intervals. To avoid the possible unfocused side area, data analysis in each photograph 
was outlined to a central 44 × 44 μm (400 × 400 pixels) area, from which the quantification of 
the surface area covered with the adhered, fluorescent bacteria was made. The fluorescent 
area was counted in square pixels with the picture-processing program Image J (National 
Institute of Health, Bethesda, MD, USA). A total of 120 digital photomicrographs in the first 
study (I) and 640 photomicrographs in the second study (II) were analyzed and included.
4.1.6  Pilot studies on bacterial adherence
Before the use of these methods with a larger study material, pilot studies were conducted to 
test the success of culturing the bacteria and measuring the bacterial adherence. First, 
culturing of the S. aureus, the albumin coating, and the contamination of four titanium plates 
(two uncoated, two albumin-coated) were tested as described in 4.1.2 to 4.1.4. Because after 
staining, the microscopic distribution of bacterial coverage on a titanium plate was uniform 
both on uncoated and albumin-coated plates, the methods could be utilized in the actual 
studies for S. aureus.
After clarification of the methods for S. aureus came a pilot study for P. aeruginos. The 
bacteria were first cultured overnight in Lur-β broth, after which two uncoated and two 
albumin-coated titanium plates were contaminated in bacterial suspension, the concentration 
of which was estimated to be 5 × 108 CFU/ml. After exposure of the plates to bacteria and 
staining, microscopy showed that the bacteria were distributed considerably unevenly in 
patches on the plates. That method was abandoned, and a second pilot for P. aeruginosa was 
conducted: culturing of the bacteria on chocolate agar plates, making the suspension, 
exposure, and staining of the plates as described above. Two uncoated and two albumin-
coated titanium plates were included. In microscopy, the bacterial distribution on the plates 
was now visually clear and uniform both on uncoated and albumin-coated plates. Finally, 
these methods were successfully exploited in the actual studies for P. aeruginosa.
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4.2  EXPERIMENTAL ANIMAL STUDY (III) 
4.2.1  PLGA middle ear implants 
Two kinds of PLGAs were tested in this study for their biocompatibility in the middle ear of 
the chinchilla. PLGA (A) plates (L82/G18 PLGA, Lactosorb®, W. Lorenz Surgical Inc., 
Jacksonville, FL, USA) were bent into an L-shape (thickness 0.75 mm, width 2 mm, longer 
lap length 3-4 mm, shorter lap length 1-2 mm) or straight cut (thickness 0.75 mm, width 2 
mm, length 5-7 mm). PLGA (B) plates (L80/G20 PLGA, Bionx Ltd., Tampere, Finland) were 
only straight cut (thickness 0.6 mm, width 2 mm, length 5-7 mm), because these plates were 
structurally more fragile, resulting in difficulties in the bending of small implants. 
4.2.2  Test animals 
Twenty-five male chinchillas, each weighing approximately 550 g, were purchased from an 
animal farm (Helsinki, Finland). The animals were housed in individual cages in the same 
room in the experimental animal unit of the Faculty of Veterinary Medicine (University of 
Helsinki, Finland). Before the actual experimental study, one animal was killed with an 
overdose of ketamine for anatomical preparation. The EAC, middle-, and inner ear of this 
animal were examined under a microscope to clarify the anatomy of these structures in the 
chinchilla. The animal had a straight EAC and a large TM and middle ear bulla. This 
observation confirmed the proposed suitability of this species for the study, after which, 24 
animals were divided into 4 groups: 10 animals for each PLGA group, 2 animals to be sham-
operated, and 2 with no operation. 
4.2.3  Experimental surgery and follow-up of the chinchillas 
Animals were anesthetized with ketamine 40 mg/kg and xylazine 4 mg/kg intra-peritoneally. 
During the surgery, norepinephrine (1:1000) was used locally for hemostasis. After 
anesthesia, both ears of each animal were photographed. The EAC and TM were imaged 
digitally through an otoendoscope before and after surgery. The right ear of each animal 
(except in the two control cases) was operated on, whereas the left ear served as a control. A 
transcanal approach was used, and a tympanomeatal flap was elevated under microscopic 
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control. A PLGA plate (either A or B) was inserted under the annulus such that the plate was 
partly under the tympanomeatal flap and partly in the tympanum under the mucosa. Eight 
animals in each study group received this implant. Two animals in each group were implanted 
such that the whole straight-cut PLGA plate was placed into the tympanum under the mucosa. 
In the sham-operated group, the tympanomeatal flap was elevated, but no implant material 
was inserted. Finally, in all animals, the tympanomeatal flap was repositioned. 
Three months after surgery, the animals were anesthetized again as described. The TMs and 
the skin of the EACs were photographed with the aid of an otoendoscope. At this point, four 
animals were lost due to complications related to anesthesia; one animal in the PLGA (A) 
group and three in the PLGA (B) group. Six months after surgery, all animals were killed with 
an overdose of ketamine. The TMs and the skin of the EACs were photographed. 
Thoracotomy was performed, and a needle was inserted into the left ventricle. The right 
auricle was opened, and the abdominal aorta was closed. All animals were perfused 
transcardially with 0.9% NaCl (200-300 ml), followed by 200 ml of 10% formalin solution. 
Both temporal bones of each animal were removed for further preparation. 
4.2.3  Tissue preparation 
In all temporal bones removed, a hole was made in their middle ear bullas. The bones were 
post-fixed overnight in the same fixative at +4°C and decalcified in 0.5 M EDTA solution at 
pH 7.4 and at +4°C until the bone was adequately soft for sectioning, typically after 7 to 10 
days. Each specimen was dissected under a microscope, and a block containing bony EAC, 
the TM, the tympanum, and the basal turn of cochlea was isolated. Samples were embedded 
in paraffin wax and cut into 5-μm sections that were stained with hematoxylin-eosin, van 
Giesson, and Masson´s trichrome for light microscopy. 
4.2.4  Analysis of the digital images 
Digital images of the EACs and TMs at four time-points (preoperatively, perioperatively, and 
at 3 and 6 months after surgery) were analyzed. Presence of TM perforations, progress in 
healing in the EAC, extrusion of biomaterial, and crusting in the EAC were recorded. 
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4.2.5  Analysis of tissue samples 
For histological evaluation, serial sections of five slides per temporal bone and four high-
power fields per slide were analyzed. The inflammatory reaction was evaluated and graded as 
none-mild-moderate-strong (0-3). The inflammatory cell infiltrates and fibrin deposits around 
the implant, under the skin of the EAC, and in the tympanal mucosa were blindly evaluated. 
Degradation of the biomaterial and neo-osteogenesis were checked. The basal turn area of the 
cochlea was also investigated, for the presence of possible hair-cell damage and any 
inflammatory reaction. Microscopy was performed with an Axioplan 2 microscope (Carl 
Zeiss, Jena, Germany), used to capture digital images to be analyzed with AxioVision 3.0 
software (Carl Zeiss). 
4.3  CONE-BEAM CT IMAGING OF TEMPORAL BONE (IV, V)
4.3.1  Temporal bones (IV, V) 
In Study IV, 13 non-operated cadaver temporal bones were imaged with CBCT and multislice 
helical CT for comparison. The bones were from the temporal bone laboratory collection of 
the Department of Otorhinolaryngology (HUCH). All the bones had intact tympanic 
membranes.
In Study V, one non-operated and five postmortem operated and implanted temporal bones 
were imaged with CBCT. The operations performed were: 1) stapedotomy with dislocated 
McGee piston prosthesis, 2) stapedotomy with McGee piston prosthesis (normal position), 3) 
atticotomy with PLGA reconstruction, 4) tympanoplasty with titanium PORP and cartilage, 
and 5) CWD procedure with PLGA and autologous bone reconstruction of the posterior wall 
of the EAC in addition to tympanoplasty with titanium PORP. The PLGA plates 
(LactoSorb®, Walter Lorenz Surgical, Jacksonville, FL, USA) had a PLA/PGA ratio of 
82/18% and thickness of 0.5 mm. 
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4.3.2  Imaging techniques and image reconstruction (IV, V) 
The 13 temporal bones (IV) were imaged with CBCT (3D Accuitomo; Morita co., Kyoto, 
Japan) (Fig. 1) at 2mA, 70kVp, and a FOV of 30 mm in height and 40 mm in axial diameter. 
The exposure time was 17.5 s, corresponding to the 360˚ rotation time of the scanner. The 
bones were fixed to the adjustable patient chair at the level of the patient’s head so that the 
focus of the cone-shaped X-ray beam was on the middle ear area (Fig. 2). The computer 
connected to the 3D Accuitomo digitalized and reconstructed the image data to be displayed 
as high-resolution images. Slice thickness in this image assessment was 0.5 mm. 
Subsequently, the bones were imaged with multislice helical CT (Aquilion 16; Toshiba, 
Tokyo, Japan) with a 180 mA, 120 kVp, and 0.75 s rotation time. Scan length was 6 cm, and 
the reconstruction FOV was 18 cm. A program for otologic imaging with a bone algorithm 
was used in the processing and reconstruction of the image data. The reconstructed slice 
thickness was 0.5 mm. 
The one non-operated and five operated temporal bones (V) were imaged with this CBCT 
equipment using four different tube current and voltage settings: 2 mA/70 kVp, 4 mA/70 kVp, 
2 mA/80 kVp, and 4mA/80 kVp. The FOV and rotation time of the scanner were as described 
above. Slice thickness in the reconstructed images was 0.5 mm. 
4.3.3  Evaluation of image quality with contrast-to-noise ratio (IV) 
To provide a quantitative assessment of image quality, the CNR was evaluated from the 
middle ear images, and equivalent images were reconstructed from a section of uniform water 
background. Contrast was measured as the mean pixel intensity difference between circular 
regions of interest placed upon the external auditory canal air volume and the bone region 
around the cochlea. Noise was determined as a standard deviation (1 SD) of the pixel intensity 
within the circular ROI placed on a water background (axial section image of a water-filled 
cylindrical plastic bottle with a diameter of 7 cm and length of 19 cm). Image analysis was 
performed with the ImageJ program (v. 1.34s; National Institutes of Health, Bethesda, MD, 
USA).
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4.3.4  Evaluation of the image quality with CNR (V) 
Image quality in this study was evaluated with the aid of a special phantom insert used for 
CNR analysis. The insert consisted mainly of PMMA (polymethylmethacrylate), had a 
cylindrical geometry, and could be placed inside a commercially available RSVP phantom 
(The Phantom Laboratory, Salem, NY, USA). The plastic shell of the RSVP phantom 
corresponded to the surface anatomy of the human head, and the phantom could be filled with 
water to simulate the physical attenuation characteristics of an in vivo situation. For CNR 
analysis of this study, the insert was positioned close to the RSVP head’s ear and surface so 
that the holes of the insert containing teflon and air were in the area of the imaginary middle 
ear and towards the surface of the RSVP. Teflon was used to simulate the bone tissue, and air 
to simulate the air spaces in the middle ear. CBCT (3D Accuitomo; Morita co., Kyoto, Japan) 
imaging of the phantom was conducted with the same four imaging protocols described above 
for the bones (4.3.2) to compare the influence on the CNR of different protocols. The FOV of 
30 x 40 mm was centered on the phantom insert. The scanner provided 3D data with isotropic 
resolution of 0.12 × 0.12 × 0.12 mm3. For the image quality analysis, axial slices of 1 mm in 
thickness were exported in DICOM (Digital Imaging and Communications in Medicine) 
format.
The CNR of two materials was calculated as the difference between the signals measured for 





The average intensity value measured inside a certain region of interest was considered as 
signal and the standard deviation of the intensity values inside the region as noise for the 
material. Image noise was calculated as the arithmetic average over the noise obtained from 
the two materials considered. CNR was calculated for teflon as well as for air against the 
PMMA background. For determination of the signals and noises for teflon and air, the ROI 
was outlined to an area of 40 x 40 pixels. The PMMA background region was limited to a 
square of 80 x 80 pixels. Analysis was performed for each axial slice of an image set, in 
which the teflon and air regions could be seen, and the final CNR was assumed to be the 
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average of the single-slice CNRs. Slices in which partial volume artifacts from the top or 
bottom plates were visible were excluded from analysis. 
4.3.6  Analysis of temporal bone images (IV, V) 
In Study IV, 16 clinically and surgically important landmarks in the middle and inner ear 
were selected for assessment and comparison (Table 2). The conspicuity of the objects in the 
CBCT and the helical CT images were evaluated according to a modified Likert scale (1=not 
seen or absent; 2=poorly seen or not diagnostic; 3=clearly seen). In addition to the 
comparison of scores of individual landmarks, total scores and scores for subgroups forming a 
specific focus of clinical interest were compared. The subgroups were: the subgroup of joints 
(incudomalleolar and incudostapedial), stapes structures (head, crura, footplate), and the 
structures around stapes (tympanic sinus, facial recess, pyramidal eminence). Analysis of all 
images was performed in the same session by two otologists and one radiologist.
The temporal bone images of Study V were analyzed systematically by the same two 
otologists and one radiologist. Based on the evaluation, the imaging protocols for the best 
result in object visualization were graded, and visualization of surgical landmarks and 
positions of the middle ear implants assessed. 
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Table 2.  Structures evaluated in the CBCT and helical CT images (IV). 


















Figure 2. Top; anatomical demarcation of the temporal bone in the skull. Bottom; site of axial 
and coronal target beams adjusted to the region of interest for imaging of the middle ear of the 
left temporal bone with CBCT (3D Accuitomo).
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4.4  STATISTICAL METHODS
In the first bacterial adherence study (I) and in the CBCT study (IV), Student’s t-test was used 
to compare the results between study groups. In the second study (II), the values of study 
groups did not conform to the normal distribution, based on the histogram analysis, and the 
non-parametric Mann-Whitney U-test was selected for the statistical comparison. In the 
animal study (III), the 2 test was used to compare the intensities of tissue reactions caused by 
the two different PLGAs. The criterion for statistical significance was p < 0.05. 
4.5  ETHICS 
The animal study (III) was approved by the Local Ethics Committee for Animal Experiments, 
HUCH, University of Helsinki, Finland, and by the Provincial State Office of Southern 
Finland. Animal experiments were conducted in accordance with the European Convention 
(1986) guidelines. The use of cadaver temporal bones (IV, V) was approved by the Ethics 
Committee of the Department of Otorhinolaryngology (HUCH, Helsinki, Finland). 
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5
RESULTS AND COMMENTS 
5.1  BACTERIAL ADHERENCE STUDIES (I, II) 
5.1.1  Bacterial adherence to titanium surfaces (I) 
The mean coverage of Staphylococcus aureus of the uncoated plates was 1.6% (95% 
confidence interval, CI, 1.1-2.0%) at the 1 × 108 CFU/ml suspension concentration and 6.5% 
(95% CI 5.3-7.6%) at the 5 × 108 CFU/ml concentration. The corresponding values with the 
albumin-coated plates for S. aureus were 0.22% (95% CI 0.16-0.28%) and 0.25% (95% CI 
0.2-0.3%). Adherence was inhibited by 82% at the 1 × 108 CFU/ml concentration (p < 0.05) 
and by 95% at the 5 × 108 CFU/ml concentration (p < 0.05). 
The mean coverage of Pseudomonas aeruginosa of the uncoated plates was 5.0% (95% CI 
4.3-5.7%) at the 1 × 108 CFU/ml suspension concentration and 25.4% (95% CI 23.4-27.3%) 
at the 5 × 108 CFU/ml concentration. The corresponding values with the albumin-coated 
plates were 3.3% (95% CI 2.5-4.0%) and 16.8% (95% CI 14.8-18.8%). The adherence was 
inhibited by 29% at the 1 x 108 CFU/ml concentration (p = 0.09, not significant) and by 37% 
at the 5 × 108 CFU/ml concentration (p < 0.05). 
The results showed a significant reduction in the adherence of S. aureus and P. aeruginosa on 
albumin-coated titanium compared to uncoated titanium at higher bacterial concentrations. 
5.1.2  Bacterial adherence to PLGA, silicone, and titanium (II) 
The mean coverage of Staphylococcus aureus on uncoated PLGA (A) was 3.35% (95% CI for 
median 2.35-3.76%), and 0.22% (95% CI for median 0.12-0.24%) on albumin-coated plates. 
For PLGA (B), the values were respectively 7.62% (95% CI for median 4.67-7.87%) and 
1.18% (95% CI for median 0.43-1.22%). For silicone, the corresponding values were 4.90% 
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(95% CI for median 3.95-5.70%) and 0.61% (95% CI for median 0.53-0.67%), and for 
titanium 10.58% (95% CI for median 6.77-13.13%) and 0.33% (95% CI for median 0.25-
0.39%) (Fig. 3). Albumin coating inhibited the adherence by 93.4% on PLGA (A), 84.5% on 
PLGA (B), 87.6% on silicone, and 96.9% on titanium (Fig. 4). The decrease in the adherence 
was significant in all groups (p < 0.0001). When compared, most of the adherence differences 
between the test materials were significant (p < 0.05), except for uncoated PLGA (B) vs. 
silicone (p = 0.201) and titanium (p = 0.117), and for albumin-coated  PLGA (B) vs. silicone 
(p = 0.665) and titanium (p = 0.050). 
The mean coverage of Pseudomonas aeruginosa on uncoated PLGA (A) was found to be 
12.73% (95% CI for median 8.85-15.40%), and 6.16% (95% CI for median 4.08-7.62%) on 
albumin-coated plates. For PLGA (B), the values were respectively 11.19% (95% CI for 
median 6.41-11.58%) and 8.55% (95% CI for median 3.19-9.62%). For silicone, the 
corresponding values were 16.94% (95% CI for median 12.12-20.86%) and 4.54% (95% CI 
for median 1.87-5.72%), and for titanium 40.45% (95% CI for median 36.66-42.88%) and 
17.78% (95% CI for median 14.84-21.20%) (Fig. 5).  The inhibitory effect of albumin on the 
adherence was significant for each material, the mean inhibition rate being 51.6% for PLGA 
(A) (p < 0.0001), 23.6% for PLGA (B) (p < 0.05), 73.2% for silicone (p < 0.0001), and 56.0% 
for titanium (p < 0.0001) (Fig. 4). Again, most of the adherence differences between the 
materials were significant (p < 0.05), except for uncoated PLGA (A) vs. PLGA (B) (p = 
0.062) and silicone (p = 0.252), as well as for albumin-coated PLGA (A) vs. PLGA (B) (p = 
0.513) and PLGA (B) vs. silicone (p = 0.366).
As in Study I, albumin coating of the plates induced a significant decrease in the adherence of 
S. aureus and P. aeruginosa to the materials tested. Furthermore, the highest adherence was 
found on titanium plates with both bacteria, and with albumin coating the differences between 
the materials diminished. On average, no more bacterial adherence occurred on the PLGA 
plates than on silicone and titanium.
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Figure 3. Mean percentage coverage of Staphylococcus aureus of the material surfaces (II). 
Figure 4. Mean percentage inhibitory effect of albumin on adherence of Staphylococcus
































Figure 5. Mean percentage coverage of Pseudomonas aeruginosa of material surfaces (II). 
5.2  EXPERIMENTAL ANIMAL STUDY (III) 
Clinically, all the ears of the animals perioperatively were healthy. In analysis of the 
otoendoscopic images taken preoperatively, perioperatively, and at 3 and 6 months after 
surgery, no perforations of the TM, infections of the EAC, or signs of otitis media were 
observable. At 3 months, images showed some crusting in the EAC, but neither perforations 
of the TM nor extrusion of the implant material. At 6 months, very minor crusting in the EAC 
had occurred, but in all operated animals the skin was intact. Neither granulation nor obvious 
inflammatory changes were present in the EAC, and the TMs were healthy. 
In histological samples, both implanted PLGA materials were mostly degraded, with some 
capsulous fibrin formation present around the PLGA plates. A small amount of inflammatory 
cell infiltrates surrounded some of the degrading material. These cell infiltrates were evident 
mainly in the degrading implant itself or on its surface facing the host tissue. They contained 

















In the surrounding skin or in the middle ear mucosa, no or at most mild inflammation had 
appeared. A few of the samples showed coccoidal bacterial colonization of the implant, but 
the inflammatory reaction in these cases was similar to that observed in the implants free of 
bacterial colonization. No hair cell damage or inflammatory reaction occurred in the area of 
the basal turn of the cochlea. Comparison of the degree of the inflammatory reaction between 
the two PLGA groups disclosed no significant difference (p = 0.157). No neo-osteogenesis in 
the samples was visible. 
The results showed no clinical complications of PLGA implantation in the chinchilla middle 
ear, TM, or EAC. Histologically, at most a mild inflammatory reaction with some fibrous 
capsule formation was observable around the implants. These findings indicate the good 
biocompatibility of PLGA implant in the middle ear in an animal model. 
5.3 CONE-BEAM CT STUDIES (IV, V) 
5.3.1  Comparison of cone-beam CT with multislice helical CT (IV) 
When scores of individual structures and subgroups were compared, no significant difference 
existed between imaging methods (p > 0.05), nor any significant difference between total 
scores for helical CT and CBCT (p = 0.9340). The structures evaluated (Table 2) were mostly 
clearly visible in the CBCT images (Figs. 6 and 7). On average, visualization of the cochlear 
and vestibular aqueducts was poor with both CBCT and helical CT.
With CBCT, the estimated mean radiation dose of the imaged section was 1.4 mGy, based on 
the standard dosimetric CT measurement set-up applying cylindrical head phantom geometry 
with 16 cm axial diameter. According to this physical dose estimation, the calculated effective 
dose was 13 µSv, which corresponds to the effective dose of half of a PA thorax radiograph. 
With multislice helical CT, the mean physical dose of the imaged section was 25.8 mGy, 
recorded from the scanner console. The effective dose was 0.6 mSv, calculated with the CT-
EXPO program using the ADAM male anthropomorphic human model (Stamm and Nagel 
2002). The CNR was more than 50% lower in CBCT than in multislice helical CT, but still 
adequate for the diagnostic task. 
68
The results showed that diagnostic imaging of the middle ear is possible with CBCT and at 
least as accurate as with multislice helical CT. The estimated effective radiation dose of the 
CBCT was over 40-fold lower than that of helical CT in this setting. 
Figure 6. Incudostapedial joint imaged by  Figure 7. Stapes imaged by CBCT (IV). 
CBCT (IV). Arrowhead: the joint; axial view. Thin arrowhead: head, and thick 
arrowhead: footplate of the stapes;  coronal 
view.
    
5.3.2  Imaging of the phantom insert and operated temporal bones with CBCT (V)
 The best CNRs in the phantom images were achieved with a tube voltage of 80 kVp and a 
current of 4 mA with both teflon and air. Based on evaluation of the bone images as well, the 
highest image quality was considered to be with this protocol. With all the temporal bones, 
image quality was good and of diagnostic value. The middle ear implants and their positions 
were clearly identified, and the dislocation of the piston prosthesis was clearly visible. In the 
images of all six temporal bones, the clinically important structures of the middle ear area 
could be identified. The PLGA plates used in the reconstructions were X-ray negative (Fig. 
8).
The results of this study showed that CBCT imaging of operated and implanted temporal 
bones was successful. With this technique, visualization of the middle ear implants and the 
auditory ossicular chain is clear, making diagnostic evaluation of these possible. 
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Figure 8. The postoperative situation after tympanoplasty with titanium PORP, CWD procedure, and 
posterior EAC wall reconstruction imaged by CBCT (V); coronal view. In addition to bone chips and 
paté, PLGA plates have been used in the reconstruction. Thick arrowhead: PORP; thin arrowhead: site 





The need is constant for improvement of surgical techniques in reconstructive middle ear 
surgery.  Surgical treatment particularly of COM and cholesteatoma pose a challenge to every 
otologist. In the treatment of adhesive otitis media, results are often poor despite attempts to 
restore a functional aerated tympanum, and lack of approriate autologous implant material 
may complicate reconstruction in cholesteatoma surgery. Consequently, synthetic implants 
are often necessary for providing structural and functional support. An ideal implant material 
in this context would be biocompatible, unlikely to cause postoperative infections, and 
suitable for reconstructive purposes in the ear. Furthermore, there should be no need for an 
implant removal operation. Perioperative decisions of the surgeon play an important role in 
the successful treatment because of the individual circumstances of every middle ear 
operation. Therefore, having the option of an implant material with intraoperatively adjustable 
properties such as pliability and plasticity would be highly desirable.
Polylactic- and polyglycolic acid-based biodegradable copolymers have long been in clinical 
use in implant surgery and may be suitable for reconstruction of the middle ear and the 
posterior wall of the EAC. Thus far, they have not been used in human middle ear surgery, 
however, and reports on their experimental use in the ear are few (Feenstra et al. 1984, 
Goycoolea et al. 1991,1992,1994, Massey et al. 2004). Studies II and III of this thesis focused 
on PLGA, and the goal was to discover the biocompatibility and suitability of this material in 
the middle ear and EAC.
Assessing the severity and extent of COM or cholesteatoma, and planning surgical treatment 
of these diseases may require CT imaging. Furthermore, CT examination may be necessary in 
evaluation of a postoperative situation or in follow-up. Although CT is an excellent diagnostic 
tool, its safety for the patient is not optimal because of relatively high radiation exposure. 
Because a wide consensus exists among clinicians as to the importance of limiting cumulative 
radiation dose to a minimum, especially when imaging children, new techniques offering 
better safety without compromises in diagnostic quality are essential. Studies IV and V were 
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inspired by the good results with CBCT in imaging of limited areas with reasonable 
irradiation. Although some have reported otologic imaging with CBCT (Dalchow et al. 
2006a,b), more studies should establish the position, indications, and settings for clinical 
CBCT in this field. A comparative study revealed the diagnostic accuracy of the CBCT in 
relation to the conventional CT (IV). In addition, applicability of CBCT to imaging of middle 
ear implants and postoperative ear was clarified (V).
6.1  BACTERIAL ADEHERENCE STUDIES (I, II) 
The bacteria chosen for the adherence studies were two typical pathogens involved in CSOM 
and in a postoperative ear infection: Staphylococcus aureus and Pseudomonas aeruginosa,
whose adhesion to biomaterial surfaces in vitro we studied and compared. Because chronic 
implant infections lead to medications, hospitalizations, re-operations, increased morbidity 
and mortality, and tremendous financial costs (Darouiche 2004, Lynch and Robertson 2008), 
every effort is necessary to prevent such postoperative infections. Antibiotic prophylaxis 
cannot, however, rule out bacterial adherence and biofilm formation on implant material in 
vivo (Keane et al. 1994, Morris et al. 1999, Lynch and Robertson 2008). Based on the 
literature, albumin coating of the biomaterial surface as a potential inhibitor of bacterial 
adherence, and thus as a preventive procedure of postoperative infection, was also tested in 
these studies.
The goals of Study I were to develop an appropriate method for quantifying bacterial 
adherence on titanium plates in vitro and to test the effect of albumin coating of the plates on 
bacterial adherence to the titanium surface. With the methods used, quantification of 
adherence to the plates was possible to determine reliably, since fluorescent staining of the 
bacteria provided a clear view of bacterial coverage in microscopy. The results were uniform 
for the bacterial species, although the inhibitory effect of albumin was more evident for S.
aureus than for P. aeruginosa. This difference is most apparently related to the adherence 
characteristics unique to each bacterial species (An and Friedman 1998); e.g., bacteria with 
fimbriae or flagellae or both (like P. aeruginosa) are able to adhere more easily than are ones 
without fimbriae (Petas et al. 1998, Morris et al. 1999). The results showed the clear 
inhibitory effect of albumin coating on bacterial adherence of S. aureus and P. aeruginosa to 
the titanium surface. 
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The results of Study II again clearly showed a uniform, significant inhibitory effect of the 
albumin coating on bacterial adherence. Adherence differences between materials diminished 
after the albumin coating, consistent with the findings of the universal antiadherent nature of 
albumin (Packham et al. 1969, Remuzzi and Boccardo 1993, Zdanowski et al. 1993, An et al, 
1996, Kinnari et al. 2001). Of the materials tested, titanium allowed the highest adherence for 
both bacteria, while less adherence occurred on PLGA- and silicone surfaces. The reasons 
may be related to the roughness and hydrophobicity of the titanium surface. Surface 
roughness has been considered an essential factor in the bacterial adhesion process (An and 
Friedman 1998, van de Belt et al. 2001). Under light microscopy, titanium surfaces appeared 
to be the roughest of all the test materials.
Furthermore, Staphylococcus aureus has been shown to have a preference for metal surface in 
vitro and in vivo, and to be the dominant microorganism associated with infected metal 
implants (Barth et al. 1989, Verheyen et al. 1993, An and Friedman 1998). Verheyen et al. 
(1993) also showed S. aureus to have a preference for metal (stainless steel) over PLA and 
composite (PLA/hydroxyapatite). Metal surfaces in general possess a hydrophilic character 
(An and Friedman 1998), and the majority of Pseudomonas aeruginosa strains have been 
shown to manifest hydrophilic properties (Hostacká et al. 2006). Keeping in mind the 
proposed general rule that bacteria with hydrophilic properties prefer hydrophilic surfaces (An 
and Friedman 1998), this observation may explain the results with P. aeruginosa in this 
respect. However, different strains of P. aeruginosa have shown essential distinctions in 
hydrophobicity, exopolysaccharide coat, and the expression of fimbriae and flagellae types 
(Elsheikh et al. 1985, Spangenberg et al. 1998, Li and Logan 2004). Furthermore, many 
reports state that the substratum or bacterial surface hydrophobicity has little or no effect on 
adherence (Sobel and Obedeanu 1984, Elsheikh et al. 1985, Hogt et al. 1985, Verheyen et al. 
1993, Karakeçili and Gümü derelio lu 2002, Palmer et al. 2007). Because of complexity, 
unknown factors, and controversies over the bacterial adhesion process, the data acquired in 
this study can lead to no conclusions as to the reasons for species-dependent bacterial 
behavior on different materials. One hypothetical reason for titanium’s being the most 
adherent test material in this setting may be the degree of its surface roughness, greater than 
for other materials.
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The focus of interest in Study II was in the PLGA materials and their characteristics in 
relation to common otologic implant materials. PLGA was chosen because of its being 
representative of both PLA and PGA, and two different PLGAs were used to exclude 
potential bias in the results. Two major questions arise regarding PLGA in this context. First, 
how does the degradation process in vivo affect the surface properties and bacterial adherence 
of PLGA? Second, do the degradation products generated in a biological environment have 
any bacteriostatic influence in situ? It has been suggested that degradation of the underlying 
material to which the bacteria are attached results in the release of bacteria, but numerous 
adhesive contacts would keep the bacteria on the surface, while individual contact points may 
be broken and—subsequently—re-form on the next exposed polymer (Stickler 1996, Petas et 
al. 1998). While the principles of bacterial adherence on the degrading material remain to be 
discovered, it is, however, justified to state that biodegradable polymers provide only a 
temporary substrate for bacterial colonization, not one lasting until the end of the degradation 
process.
Ludwick et al. (2006), who investigated the attachment of S. aureus and P. aeruginosa to 
experimental PLA-tympanostomy tubes by incubating the tubes in bacterial suspensions for 
48 h, found significantly lower counts of both bacteria on the PLA tubes than on the control 
fluoroplastic tubes. They concluded that PLA has an apparent bacteriostatic quality that is 
possibly related to its acidic nature. However, Petas et al. (1998) found no evidence in vitro 
for this hypothesis, according to which the degradation products of PLA or PGA would create 
an acidic microenvironment unfavorable for bacterial growth and adhesion during 
degradation; the follow-up in that study was up to 28 days. They suggested that the acidic 
potential of the metabolites would be too low to induce a local decrease in pH, or that the 
change in pH would be small enough—due to the slow degradation rate—to be quickly 
neutralized by the liquid medium. On the other hand, while some reports support the theory 
that rapid degradation of pure PGA reduces implant biocompatibility by releasing significant 
amounts of glycolic acid (Böstman and Pihlajamäki 2000), it is obvious that this issue still 
remains under debate.
Since the results of Studies I to II were similar with both bacteria, they can be considered 
reliable. However, because of the complexity and multiple contributory factors of the 
bacterial adhesion process in vivo, conclusions based on the results of these in vitro studies 
should be made with caution. First, the in vitro conditions differed markedly from an in vivo 
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situation with regard to bacterial concentration, temperature, and physicochemical and tissue-
specific factors in living tissue. Second, these circumstances also lacked certain competitive 
factors for bacterial adhesion, such as the presence of other microbes, proteins, and the host’s 
immune mechanisms. However, this model may be considered sufficient and reliable for 
suggestive results. The literature provides numerous studies and conclusions on biomaterials 
based on in vitro findings, and, concerning bacterial adhesion, these have been consistent with 
in vivo findings (Barth et al. 1989, An et al. 1996 and 1997, al-Khaffaf and Charlesworth 
1996, Kinnari et al. 2001, 2004, 2005). 
6.2  EXPERIMENTAL ANIMAL STUDY (III) 
The goal of this study was to determine the suitability of PLGA in experimental ear surgery. 
Since the chinchilla has been a successful model for experimental ear surgery (Amoils et al. 
1992, Downey et al. 2003, Siedentop et al. 2004, Spiegel and Kessler 2005), that animal was 
chosen also for this study. Anatomical preparation revealed the chinchilla to have a straight 
EAC and a large TM and middle ear bulla, confirming the suitability of chinchillas for the 
experiment. PLGA was chosen as the implant material, because, first, it represents both PLA 
and PGA copolymers. Second, commercial PLGA products have a resorption time (1-2 years) 
suitable for testing the hypothesis of this study. Pure PGA has a high degradation rate, and its 
biocompatibility has been reported to be lower than that of PLA (Böstman and Pihlajamäki 
2000). Pure PLA in turn degrades very slowly, which presumably would not be a goal for 
such implant in the ear. In addition, in ear surgery, the implant mechanical strength required is 
far from that of the osteosynthetic plates used in orthopedic and CMF surgery. Third, PLGA 
has a capacity to be easily and intraoperatively reshaped by heating, which is important when 
reconstructing such structures as the posterior wall of the EAC according to the dimensions of 
each individual’s anatomy. 
PLGA plates were inserted under the skin of the EAC (in contact with bone) and the mucosa 
of the tympanic cavity. Neither in clinical follow-up nor in histological samples were any 
major adverse responses to the implantation evident. The mild inflammation with minor 
fibrosis was as expected and in accordance with reports on PLGA biocompatibility. Nor did 
any toxic effects on the inner ear occur. These results confirm the suitability of PLGA in ear 
surgery in a chinchilla model and support the findings of Goycoolea et al. (1991, 1992, 1994), 
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who also used the chinchilla in studies of a PLA-based drug-delivery device. Furthermore, 
Massey et al. (2004) investigated PLA- and PLGA tympanostomy tubes in guinea pigs with 
good results. Less successful results occurred with PLA grafts in myringoplasty of mongrel 
dogs, however, (Feenstra et al. 1984), as PLA induced more marked inflammatory reaction 
than in rats in that study. Results from an animal model should be considered preliminary and 
not with certainty applicable to human beings. Because knowledge of biocompatibility of 
PGA, PLA, and PLGA in the middle ear is scarce, more animal research is perhaps needed to 
verify their suitability in this regard. On the other hand, vast clinical experience in surgery 
using these materials routinely has demonstrated their good biocompatibility, which favors 
conducting of prospective studies on use of these polymers in the human ear.
The temporary and non-magnetic nature of a biodegradable PLGA implant reduces the 
probability of long-term problems compared to those of permanent non-degradable 
biomaterials. On the other hand, because of the provisional character of biodegradable 
polymers, they would be suitable for specified purposes only. One potential application would 
be a biodegradable scaffold in the myringoplasty, where the requirements for functional 
temporary graft include sufficient mechanical strength, softness and pliability, surviving until 
complete regeneration of migrating epithelium from the membrane remnants, and a 
biocompatibility that in particular allows attachment of neo-epithelium to the implant surface. 
The mild fibrosis produced in the degradation may strengthen the neo-membrane and function 
as a substitute for the absent collagen middle layer. Alloplastic material instead of autologous 
cartilage or temporal fascia can reduce operation time; the implant can have a predictable 
resorption rate and can serve in situations where alloplastic material use is justified, for 
instance, in congenital or atelectatic ears and subtotal perforations with loss of the malleus 
(Feenstra et al. 1984). In surgery for COM or cholesteatoma, postoperative medialization of 
the TM and collapse of the tympanum is a danger. A biodegradable stent supporting the TM 
at the annulus might prevent the TM’s intense retraction after surgery. Again, fibrosis 
resulting from the degradation may provide additional support, especially in the long term 
after implant dissolution.
In reconstruction of the posterior wall of the EAC and in mastoid obliteration, numerous 
techniques have been applicable with both biological and synthetic materials, but no single 
combination has proven ideal for reliable reconstruction of the posterior canal wall anatomy 
(Black 1995, Leatherman ad Dornhoffer 2002). Modified PLA- or PLGA plates placed under 
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the skin and cartilage against the bone chips and paté may be useful in giving structural 
support and preventing collapse and cavity formation in the wall during healing. The fibrosis 
induced may strengthen the effect. PLA implants covering bone defects have prevented the 
invasion of the soft tissues into the neo-osteogenesis area (Giardino et al. 2006, Schmidmaier 
et al. 2006). What is still controversial is whether pure PLA has an osteoinductive effect. 
Meanwhile, bioglass possessing excellent biocompatibility has not only served as a scaffold 
for bone regeneration but also stimulated osteoblast activity and neo-osteogenesis. 
Furthermore, bioglass also has a bacteriostatic quality (Peltola et al. 1998, Aitasalo et al. 
2001, Blaker et al. 2003, Stoor and Grénman 2004, Stoor et al. 2006). Consequently, based on 
promising results with the use of bioglass in posterior wall reconstruction (Reck and Helms 
1985, Leatherman and Dornhoffer 2002) and good experience with hydroxyapatite ceramics 
(Jahn 1992, Grote 1998), use of PLA/bioglass- or PLA/hydroxyapatite composites (Blaker et 
al. 2003, Hasegawa et al. 2007) for bone tissue engineering in the posterior wall and 
mastoidectomy cavity appears to have interesting potential. Because bioglass or 
hydroxyapatite alone is relatively difficult to mold into complex structures, the combination 
of PLA and ceramics would better meet this demand.
6.3  CONE-BEAM CT STUDIES (IV, V) 
The main goals of Study IV were to evaluate the diagnostic accuracy of CBCT in imaging the 
middle ear structures and to compare the results with those from multislice helical CT. The 
CBCT equipment (3D Accuitomo) was designed for dental imaging, but was considered to be 
adequate for this pilot study. The helical CT (Aquilion) and the algorithm were routinely 
employed in the department in otologic imaging. Cadaver temporal bones were successfully 
imaged with both modalities, and according to the scaled evaluation of the images, there 
proved to be no significant differences in the precision of the methods in this setting. The 
estimated effective radiation dose of the CBCT was nearly 50-fold less than that calculated 
for the helical CT. The CNR—a generally accepted instrument for the assessment of the 
image quality (Siewerdsen et al. 2006)—was more than 50% lower in CBCT than in 
multislice helical CT, but still adequate for this diagnostic task. 
The aim of Study V was to test the applicability of CBCT to the imaging of postoperative ear 
and middle ear implants. In addition, the image qualities obtained with different imaging 
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protocols were objectively compared by comparison of the CNRs calculated for the phantom 
images. The best CNRs of the phantom images were achieved with the highest tube current 
and voltage. However, the quality of bone images was graded as at least satisfactory with all 
the protocols. Furthermore, the protocol of values 2 mA/70 kVp produces the lowest radiation 
exposure, and it was used in Study IV with good results. These facts may support use of this 
protocol in prospective clinical pilot studies on otologic CBCT, although Dalchow et al. 
(2006b) used 8 mA/80 kVp when imaging patients with conductive hearing loss. As in Study 
IV, CBCT proved accurate in showing middle ear structures at a diagnostic level. 
Furthermore, visualization of middle ear implants was exact and in accordance with the 
procedures performed. Dislocation as well as the normal position of the piston prosthesis were 
detectable and locations of the titanium PORPs clearly visible.
Our findings on the diagnostic quality attained with CBCT support those of Dalchow et al. 
(2006a,b), who considered CBCT very accurate in showing anatomical details and the 
positions of ossicular replacement prostheses and of a cochlear implant. Thus, CBCT may be 
considered an alternative for helical CT in otologic imaging. Due to the limited FOV of the 
CBCT used, part of the mastoid was cut off the images. This clear disadvantage can be 
eliminated by enlarging the FOV sufficiently; this is enabled by current devices (Araki et al. 
2004, Robinson et al. 2005) allowing imaging of the whole temporal bone area. Greater FOV 
also leads to increased irradiation required, however. In addition, with CBCT, only one ear 
can be examined at a time; consequently, when bilateral imaging is necessary, radiation dose 
doubles. Furthermore, differences appeared between the scan techniques and imaging 
protocols of the CBCT and the helical CT. Consequently, an exact and ultimate comparison of 
radiation doses directly applicable to clinical practice cannot be made on the basis of Study 
IV, although the mathematical comparison yielded a great difference between the doses of 
CBCT and helical CT. Low-dose settings in multislice helical CT can substantially reduce 
radiation dose, and in dental imaging the differences between the doses of CBCT and low-
dose multislice CT have been relatively small (Cohnen et al. 2002, Suomalainen et al. 2008). 
However, with low-dose settings, the quality of the images also decreases, preventing soft-
tissue differentiation and visualization of some sub-millimeter structures at diagnostic level. 
When the skull of an actual patient is imaged instead of a cadaver temporal bone, between X-
ray source and detector there lies more absorbent material out of the FOV. This causes a 
potential increase in the appearance of image artifacts and a decrease in low-contrast 
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resolution, due to beam hardening and X-ray scattering. In multislice helical CT, the 
attenuating structures of the patient’s head are included in the scan FOV, which is a clear 
advantage of multislice CT over CBCT, when diagnostic resolution of soft tissues is required. 
In addition, the lower CBCT radiation dose leads to greater image noise and thus poorer low-
contrast resolution (Robinson et al. 2005). However, the latest advances in CBCT technology 
have introduced new techniques and software algorithms for X-ray scatter estimation and 
correction, and for improving CNR and low-contrast resolution (Gomi et al. 2006, Siewerdsen 
et al. 2006, Tu et al. 2006, Graham et al. 2007). On the other hand, in imaging the middle and 
inner ear, visualization of small bony structures and cavities is most essential, and this 
requirement is well accomplished by CBCT—according to some reports even better than by 
multislice CT (Hashimoto et al. 2003, 2007, Sukovic 2003, Winter et al. 2005, Suomalainen 
et al. 2008). Furthermore, advantages for CBCT in general include a lower level of metal 
artifacts in images, and smaller, lower-priced, mobile equipment than for conventional CT 
(Scarfe et al. 2006).
Applying CBCT to clinical otological imaging requires a scanner model with a FOV 
sufficient for imaging of the whole temporal bone. Regardless of whether the patient is sitting 
or supine when imaged, the position and support of the patient’s head must be correct. 
Optimal scan protocols for otological CBCT are vital, and also specified clinical indications 
for the examination. Furthermore, further comparable data on radiation doses of different CT 
modalities is essential.
In summary, based on the pilot studies conducted, justification exists for clinical studies on 






There proved to be no more adherence of Staphylococcous aureus and Pseudomonas
aeruginosa to PLGA than to silicone and titanium in vitro, indicating that the PLGA is an 
implant material as safe as silicone and titanium in this respect. Albumin coating significantly 
inhibited the adherence of these bacteria to PLGA, silicone, and titanium, suggesting that this 
method may be useful in implant surgery in specified situations for prevention of 
postoperative infections and improvement of implant biocompatibility.
PLGA showed good biocompatibility in the chinchilla middle ear within the 6-month follow-
up, causing only a mild inflammatory response in the middle ear mucosa without signs of 
toxicity to the inner ear. No evident differences emerged in the biocompatibility of two 
different PLGA materials. Based on these results, prospective human studies on PLGA in ear 
surgery can be encouraged.
Limited cone-beam CT was at least as accurate as multislice helical CT in showing clinically 
important landmarks in the temporal bone. Positions of middle ear implants in relation to 
surrounding structures could be reliably evaluated with CBCT. In these images, PLGA 
appeared X-ray negative. The estimated effective radiation dose of CBCT was essentially 
lower than that of helical CT. Such findings support the implementation of prospective human 
studies on otologic CBCT for specifying indications and settings for clinical practice.
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